Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
David Allan Cameron
Based on 98 articles published since 2007
||||
Expertise Level
The expertise of David Allan Cameron ranks in the
  • Top 0.015%
  • ... of 253,558 published authors worldwide on Breast Neoplasms
  • ... from 2007 through 2018
  • ... based on contributions to 98 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Cameron, D A   ·   Cameron, David A   ·   Cameron, David   ·   Cameron, David Allan
Work Locations
Details
Most likely:    University of Edinburgh      
2018
  • Edinburgh Cancer Centre, Western General Hospital, Edinburgh EH4 2XU, UK. Electronic address: · Edinburgh Cancer Centre, Western General Hospital, Edinburgh EH4 2XU, UK. · Pubmed 29303722
2017
  • Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, UK. Electronic address: · Clinical Trials Research Unit, University of Leeds, Leeds, UK. · IMIM-CIBERONC, Barcelona; Medical Oncology Department, Hospital del Mar, Barcelona, Spain; Pompeu Fabra University, Barcelona, Spain. · Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Deakin University, Geelong, VIC, Australia. · Cancer Research UK Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK. · St James Institute of Oncology, St James Hospital, Leeds, UK. · Inbiomotion, Barcelona, Spain. · Fundación Jiménez Díaz, Madrid, Spain; CIBERONC, Madrid, Spain. · IMIM-CIBERONC, Barcelona; Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. · Pubmed 29037984
  • Cancer Research UK Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK. Electronic address: · ICR-CTSU, Division of Clinical Studies, Institute of Cancer Research, London, UK. · Department of Oncology, Beatson Hospital, Glasgow, UK. · St James' Institute of Oncology, University of Leeds, Leeds, UK. · Department of Oncology, Weston Park Hospital, Sheffield, UK. · Department of Diagnostic Development, Ontario Institute for Cancer Research, Toronto, ON, Canada. · Department of Oncology, Shrewsbury & Telford Hospitals NHS Trust, Shrewsbury, UK. · Department of Oncology, Singleton Hospital, Swansea, UK. · Department of Oncology, Royal Sussex County Hospital, Brighton, UK. · Department of Oncology, Royal Stoke University Hospital, Stoke-on-Trent, UK. · Department of Oncology, Addenbrooke's Hospital, Cambridge, UK. · Department of Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK. · Cancer Research UK Clinical Trials Unit, University of Birmingham, UK. · Clinical Trials Research Unit (CTRU), University of Leeds, Leeds, UK. · Department of Oncology, Royal Surrey County Hospital, Guildford, UK. · Department of Oncology, Southampton General Hospital, Southampton, UK. · Cancer Clinical Trials Unit Scotland (CaCTUS), Glasgow, UK. · Department of Oncology, NIHR University College London Hospitals Biomedical Research Centre, London, UK. · Department of Oncology, Northern Centre for Cancer Care, Freeman Hospital, Newcastle, UK. · Department of Oncology, Christie Hospital, Manchester, UK. · Department of Oncology, Velindre NHS Trust, Cardiff, UK. · Pubmed 28600210
  • Department of Radiotherapy, Institut Bergonié Unicancer, Bordeaux, France. · EORTC, Statistics Department, Avenue Emmanuel Mounier 83b11, 1200 Brussels, Belgium. · Western General Hospital, Edinburgh Cancer Centre, Crewe Road South, GB Edinburgh EH4 2XU, United Kingdom. · Department of Medical Oncology, Institut Bergonié Unicancer, Univ. Bordeaux, INSERM U1218, INSERM CIC1401 Bordeaux, France. Electronic address: · Pubmed 28527420
  • Li Ka Shing Centre, Cancer Research UK Cambridge Institute. · Department of Pathology. · Institute of Astronomy, University of Cambridge, Cambridge. · Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge. · Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Ontario Institute for Cancer Research, Toronto, Canada. · Pubmed 28525534
  • Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge, UK. Electronic address: · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Leeds Institute for Clinical Trials Research, University of Leeds, Leeds, UK. · Cancer Research UK Clinical Trials Unit (CRCTU), Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. · Scottish Clinical Trials Research Unit, NHS Natio nal Services Scotland, Edinburgh, UK. · The Christie NHS Foundation Trust, Manchester, UK. · Department of Oncology, Shrewsbury & Telford Hospitals NHS Trust, Shrewsbury, UK. · Department of Oncology, Clatterbridge Cancer Centre, Wirral, UK. · Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK. · Department of Oncology, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Exeter Oncology Centre, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK. · Department of Oncology, Poole Hospital, Poole Hospital NHS Foundation Trust/Bournemouth University, Poole, Dorset, UK. · Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Edith Cavell Campus, Peterborough City Hospital, Peterborough and Stamford Hospitals NHS Foundation Trust, Peterborough, UK. · Cancer Research UK Edinburgh Centre, MRC Institute of Genetics & Molecular Medicine, University of Edinburgh, Edinburgh, UK. · Institute of Oncology, St James's University Hospital, Leeds Teaching Hospital NHS Trust, Leeds, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge UK; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge, UK. · NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Department of Histopathology, Cambridge, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge, UK. · Cancer Clinical Trials Unit (CaCTUS), Beatson West of Scotland Cancer Centre, Glasgow, UK. · Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland. · Cancer Trials Ireland (formerly ICORG), Dublin, Ireland. · Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, UK. · Department of Surgery and Cancer, Charing Cross Hospital, Imperial College London, London, UK. · Celgene, Research and Development, San Diego, CA, USA. · NIHR/CRUK Christie Clinical Research Facility, Manchester, UK. · Arden Cancer Research Centre, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK. · Pubmed 28479233
  • EORTC Headquarters, Brussels, Belgium. · EORTC Headquarters, Brussels, Belgium. · Department of Medical Oncology, National Cancer Institute- Cairo University, Cairo, Egypt. · Department of Medical Oncology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands. · Department of Medical Oncology, Antwerp University Hospital, Edegem, Belgium. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Ontario Institute for Cancer Research, Toronto, Ontario, Canada. · University of Edinburgh Cancer Research Center, Western General Hospital, Edinburgh, UK. · Department of Medical Oncology, New Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · University of Edinburgh Cancer Research Center, Western General Hospital, Edinburgh, UK. · Pubmed 28324265
  • University of Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. Electronic address: · Department of Medicine, Université Libre de Bruxelles, Brussels, Belgium. · BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA, USA. · Frontier Science Scotland Ltd, Kincraig, Kingussie, UK. · European Institute of Oncology, Milan, Italy. · Medical Oncology Clinic, Université Libre de Bruxelles, Brussels, Belgium. · Clinical Oncology, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. · Helios Klinikum Berlin Buch, Multidisciplinary Breast Cancer Center, Berlin, Germany. · Breast Unit, Royal Marsden Hospital, and The Institute of Cancer Research, London, UK. · Department of Medical Oncology, San Raffaele Hospital, Scientific Institute, Milan, Italy. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · F Hoffmann-La Roche, Basel, Switzerland. · Avera Cancer Institute Center for Precision Oncology, Sioux Falls, SD, USA. · Deakin University, Waurn Ponds, VIC, Australia. · Department of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany. · Pubmed 28215665
  • Department of Pathology, Western General Hospital, Edinburgh, EH4 2XU, UK. · Leeds Institute of Cancer and Pathology, St James's University Hospital, Leeds, LS9 7TF, UK. · Department of Radiation Oncology, Netherlands Cancer Institute, Postbus 90203, 1006 BE, Amsterdam, Netherlands. · Academic Medical Center, University of Amsterdam, 1105 AZ, Amsterdam, Netherlands. · Scottish Clinical Trials Research Unit, NHS National Services Scotland, Edinburgh, EH12 9EB, UK. · Centre of Population Health Sciences, Edinburgh University Medical School, Edinburgh, EH8 9AG, UK. · Edinburgh Cancer Centre, Western General Hospital, Edinburgh, EH4 2XU, UK. · Ontario Institute for Cancer Research, Toronto, ON, M5G0A3, Canada. · Beatson Oncology Centre, Gartnavel Campus, Glasgow, G12 0YN, UK. · Pubmed 28190252
  • EORTC, Statistics Department, Avenue Emmanuel Mounier 83b11, 1200 Brussels, Belgium. Electronic address: · EORTC, Medical Department, Avenue Emmanuel Mounier 83b11, 1200 Brussels, Belgium. Electronic address: · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: · Department of Medical Oncology, Institut Bergonié Unicancer, INSERM CIC1401, Bordeaux, France. Electronic address: · Western General Hospital, Edinburgh Cancer Centre, Crewe Road South, GB Edinburgh EH4 2XU, UK. Electronic address: · EORTC, Statistics Department, Avenue Emmanuel Mounier 83b11, 1200 Brussels, Belgium. Electronic address: · Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Australia. Electronic address: · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: · Pubmed 28027521
  • Mount Vernon Cancer Centre, Rickmansworth Road, Northwood, London, HA6 2RN, UK. Electronic address: · University of Edinburgh and Cancer Services, NHS Lothian, Western General Hospital, Crewe Road South, Edinburgh, EH4 2XU, UK. · Oncology Department, Dnipropetrovsk Medical Academy, Multiprofile Clinical Hospital, #449102, Blizhnaya Str, Dnipropetrovsk, Ukraine. · NN Blokhin Cancer Centre, Kashirskoye Schosse 23, Moscow, 115478, Russia. · Centro Hemato Oncológico Panama, Marbella Edificio Royal Center, 5to. Piso Torre B, Panama City, Panama. · Medical Oncology Department, National Oncology Institute, Gorgas & Juan de Arco Street, Ancon, PO Box 0816-04433, Panama City, Panama. · Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, South Korea. · Oncology and Haematology Service, Grand Hôpital de Charleroi, Grand Rue 3, 6000, Charleroi, Belgium. · Lviv State Oncological Regional Treatment and Diagnostic Center, 2a Hashek Str, Lviv, 79031, Ukraine. · Sarah Cannon Research Institute and Tennessee Oncology, PLCC, 3322 West End Avenue, Suite 900TN, Nashville, TN, 37203, USA. · Department of Surgery, Breast Oncology, National Hospital Organization Osaka National Hospital, 2-1-14, Hoenzaka, Chuou-ku, Osaka, 540-0006, Japan. · Center for Breast Cancer, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do, 10408, South Korea. · Virginia Cancer Specialists Research Institute, US Oncology, 1635 N. George Mason, Suite 170, Arlington, VA, 22205, USA. · Biostatistics Oncology, Pharma Development, F. Hoffmann-La Roche, Building 670, Malzgasse 30, 4070 Basel, Switzerland. · Global Development BioOncology, Genentech Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. · Baylor Charles A. Sammons Cancer Center, US Oncology and Texas Oncology, 3410 Worth Street, Suite 400, Dallas, TX, 75246, USA. · Pubmed 27817944
  • Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK; Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK. Electronic address: · Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK. · Department of Clinical Oncology, Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, Northwood, UK. · Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK. · Ontario Institute for Cancer Research, Toronto, Ontario, Canada. · Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK. · Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow, UK. · Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. · Independent Cancer Patients' Voice, London, UK. · National Institute for Health Research, University College London Hospitals Biomedical Research Centre, London, UK. · University of Alberta, Edmonton, Alberta, Canada. · Pubmed 29241890
  • Department of Pathology, Western General Hospital, Edinburgh, UK. · NIHR Cambridge Biomedical Research Centre, Addenbrookes Hospital, Cambridge, UK. · Cambridge Breast Cancer Research Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Department of Histopathology, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Cambridge Clinical Trials Unit-Cancer Theme, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, King's Lynn, UK. · University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK. · Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Peterborough City Hospital, Edith Cavell Campus, Peterborough, UK. · Nottingham University Hospital (City Campus), Nottingham, UK. · West Middlesex University Hospital, Isleworth, UK. · Poole Hospital NHS Foundation Trust, Poole, UK. · Bournemouth University, Poole, UK. · The Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK. · Institute for Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Ontario Institute for Cancer Research, MaRS Centre, Toronto, ON, Canada. · University of Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. · Department of Medical Oncology, NHS Lothian, Western General Hospital, Edinburgh, UK. · Pubmed 28548129
  • Department of Oncology, University of Cambridge, Cambridge. · NIHR Cambridge Biomedical Research Centre, Cambridge. · Cambridge Breast Cancer Research Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Warwick Clinical Trials Unit, University of Warwick, Coventry. · Cambridge Clinical Trials Unit - Cancer Theme, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Department of Oncology, Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, King's Lynn. · Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge. · Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Department of Oncology, Peterborough and Stamford Hospitals NHS Foundation Trust, Peterborough. · Department of Oncology, Nottingham City Hospital, Nottingham. · Department of Oncology, West Middlesex University Hospital, Isleworth. · Department of Oncology, Poole Hospital NHS Foundation Trust/Bournemouth University, Poole. · Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, UK. · Ontario Institute for Cancer Research, MaRS Centre, Toronto, Canada. · Cancer Research Centre, University of Edinburgh, IGMM, Western General Hospital, Edinburgh. · Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Department of Pathology, University of Edinburgh, Edinburgh, UK. · Pubmed 28459938
2016
  • Karolinska Institutet and University Hospital, Stockholm, Sweden · Sunnybrook Odette Cancer Centre and University of Toronto, Toronto, Ontario, Canada. · University of Edinburgh Cancer Research Centre, Edinburgh, United Kingdom. · Pubmed 26786914
  • MRC Clinical Trials Unit, UCL, Aviation House, 125 Kingsway, London WC2B 6NH, UK. · Independent Cancer Patient Voices, 17 Woodbridge Street, London EC1R 0LL, UK. · NCRI Consumer Forum, Angel Building, 407 St John Street, London EC1V 4AD, UK. · Room No. 1109, 11th Floor, Homi Bhabha Block, Tata Memorial Centre/Hospital, Parel, Mumbai 400012, India. · Department of Surgical Oncology, Tata Memorial Centre, Dr Ernest Borges Marg, Parel, Mumbai 400012, India. · MRC Clinical Trials Unit, UCL, Aviation House, 125 Kingsway, London WC2B 6NH, UK; Sussex Cancer Centre, Royal Sussex County Hospital, Eastern Road, Brighton, Sussex BN2 5BE, UK. · Room 2F65, Block A2, Cardiff School of Medicine, Heath Park, Cardiff CF14 4XN, UK. · Edinburgh Cancer Research Centre, University of Edinburgh, Western General Hospital, Crewe Road South, EH4 2XR, UK. · Centre for Cancer Research and Cell Biology, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, Northern Ireland, UK. · The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey SM2 5PT, UK. · MRC Clinical Trials Unit, UCL, Aviation House, 125 Kingsway, London WC2B 6NH, UK. Electronic address: · Pubmed 27777129
  • EORTC-Headquarters, Medical Department, Brussels, Belgium. Electronic address: · Acıbadem Üniversitesi İç Hastalıkları/Tıbbi Onkoloji, Turkey. Electronic address: · EORTC-Headquarters, Statistical Department, Belgium. Electronic address: · Institute Bergonie, Bordeaux, France. Electronic address: · GZA Sint Augustinus, Antwerp, Belgium. Electronic address: · Ctr Becquerel-Rouen, France. Electronic address: · Radboudumc Nijmegen/Maastricht UMC+, Netherlands. Electronic address: · ZNA Middelheim, Belgium. Electronic address: · University Clinic Golnik, Slovenia. Electronic address: · Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. Electronic address: · NHS-Lothian, University of Edinburgh, Edinburgh, United Kingdom. Electronic address: · Pubmed 26724641
  • Department of Oncology, University College London Hospitals, London, UK. · Warwick Medical School, University of Warwick, Coventry, UK. · Ontario Institute for Cancer Research, Toronto, ON, Canada. · Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK. · School of Social and Community Medicine, University of Bristol, Bristol, UK. · Independent Cancer Patients' Voice, London, UK. · Research Oncology, Division of Cancer Studies, King's College London, London, UK. · Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK. · Department of Emergency Medicine, University of Alberta, Edmonton, AB, Canada. · Oncology Centre, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundations Trust, Cambridge, UK. · Department of Clinical Oncology, Mount Vernon Cancer Centre, Mount Vernon Hospital, Northwood, UK. · Pubmed 26867046
  • Leeds Institute for Clinical Trials Research (LICTR), University of Leeds, Clinical Trials Research House, 71-75 Clarendon Road, Leeds, LS2 9JT, UK. · Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Deakin University, Geelong, Australia. · St. James's Academic Division of Medical Physics, University of Leeds, Leeds, UK. · Leeds Institute for Clinical Trials Research (LICTR), University of Leeds, Clinical Trials Research House, 71-75 Clarendon Road, Leeds, LS2 9JT, UK. · Sheffield Cancer Research Centre, Sheffield, UK. · Edinburgh University, Edinburgh, Scotland. · Pubmed 26783036
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue Yawkey, Boston, 1238, USA. · Department of Medical Oncology and Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Frontier Science (Scotland) Ltd, Kincraig, Kingussie, UK. · Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Breast Unit, Royal Marsden Hospital, and Institute of Cancer Research, London, UK. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Edinburgh Cancer Research Centre, Western general Hospital, University of Edinburgh, Crewe Road South, Edinburgh, UK. · Department of Gynecology and Obstetrics and Multidisciplinary Breast Cancer Center, Helios Klinikum, Berlin-Buch, Germany. · Department of Gynecology and Obstetrics, Klinikum Off enbach, Off Enbach, Germany. · Department of Medical Oncology, The Andrew Love Cancer Centre, Deakin University, Geelong, Australia. · Department of Medical Oncology, San Raffaele Institute, Milan, Italy. · European Institute of Oncology, Milan, Italy. · Swiss Center for Breast Health, Sant'Anna Clinic, Lugano-Sorengo, Switzerland. · Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute, Harvard School of Public Health, Harvard Medical School, Boston, USA. · Pubmed 26708471
2015
  • Department of Histopathology and NIH Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, UK. · Department of Pathology, Yale University, New Haven, CT, USA. · Department of Pathology, European Institute of Oncology and University of Milan, Milan, Italy. · Edinburgh Cancer Research UK Centre,University of Edinburgh, Edinburgh, UK. · Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA. · Institute of Pathology, Charité Hospital, Berlin, Germany. · Department of Biopathology, Institut Bergonié, Bordeaux, France. · Department of Pathology, Centre Jean Perrin and Université d'Auvergne, Clermont-Ferrand, France. · Division of Subspecialty General Surgery, Mayo Clinic, Rochester, MN, USA. · Early Drug Development for Innovative Therapies Division, European Institute of Oncology, Milan, Italy. · Edinburgh Breast Unit, Western General Hospital, Edinburgh, UK. · Carol Franc Buck Breast Care Center, University of California, San Francisco, CA, USA. · Department of Radiotherapy and Radiation Oncology, Landeskrankenhaus, Paracelsus Medical University, Salzburg, Austria. · Department of Gynecology and Obstetrics, Interdisciplinary Breast Center, Klinikum Esslingen, Esslingen, Germany. · Institute of Pathology, Medical University of Graz, Graz, Austria. · Department of Gynecology, General Hospital Leoben, Leoben, Austria. · German Breast Group, Neu-Isenburg, and Department of Gynecology and Obstetrics, University Women's Hospital, Frankfurt, Germany. · Department of Radiation Oncology, Ohio State University, Columbus, OH, USA. · Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26205180
  • University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK; NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK. Electronic address: · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Cambridge Clinical Trials Unit-Cancer Theme, Cambridge University Hospitals NHS Foundation Trust, UK. · University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK; NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Western General Hospital, Edinburgh, UK. · NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Cancer Research UK Cambridge Institute, Cambridge, UK. · Peterborough City Hospital, Edith Cavell Campus, Peterborough, UK. · Nottingham University Hospital (City Campus), Nottingham, UK. · West Middlesex University Hospital, Isleworth, UK. · Royal Bournemouth Hospital, Bournemouth University, Bournemouth, UK. · The Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK. · City Hospital, Dudley Road, Birmingham, UK. · Ontario Institute for Cancer Research, MaRS Centre, Toronto, Ontario, Canada; Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. · University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK; NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK; Cancer Research UK Cambridge Institute, Cambridge, UK. · Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. · Pubmed 25975632
  • Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK. Electronic address: · Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK. · Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK. · Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK. · Pubmed 25637340
  • University of Edinburgh Cancer Research Centre, Institute of Genetics and Molecular Medicine, Western General Hospital, Edinburgh EH4 2XU, UK. Electronic address: · Pubmed 26363986
  • School of Pharmacy, Queen's University Belfast, Belfast, United Kingdom. · Warwick Clinical Trials Unit, University of Warwick, Coventry, United Kingdom. · Conway Institute, University College Dublin, Dublin, Ireland. · Ontario Institute for Cancer Research, Toronto, Canada. · Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, United Kingdom. · Royal College of Surgeons Ireland, Dublin, Ireland. · Northern Ireland Molecular Pathology Laboratory, CCRCB, Queens University Belfast, Belfast, United Kingdom. · Department of Pathology, Royal Group of Hospitals, Grosvenor Road, Belfast, United Kingdom. · Edinburgh Breast Unit, The University of Edinburgh, Edinburgh, United Kingdom. · Department of Clinical Sciences, Lund University, Sweden. · Edinburgh Cancer Research Centre, The University of Edinburgh, Edinburgh, United Kingdom. · Pubmed 25906750
  • US Food and Drug Administration, Silver Spring, MD 20993, USA. Electronic address: · Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · San Raffaele Scientific Institute, Milan, Italy. · Edinburgh Cancer Research Center, University of Edinburgh and NHS Lothian, Edinburgh, UK. · German Breast Group, Neu-Isenburg, Germany. · Pubmed 25706464
2014
  • US Food and Drug Administration, Silver Spring, MD, USA. Electronic address: · US Food and Drug Administration, Silver Spring, MD, USA. · HELIOS Klinikum, Berlin, Germany. · German Breast Group, Neu-Isenburg, Germany. · National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA. · Institut Bergonié INSERM U916 and Université Bordeaux Segalen, Bordeaux, France. · Edinburgh Cancer Research Centre, University of Edinburgh and NHS Lothian, UK. · San Raffaele Scientific Institute, Milan, Italy. · Fondazione Michelangelo, Milan, Italy. · Medstar Washington Hospital Center, Washington, DC, USA. · EORTC Headquarters, Brussels, Belgium. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. · St Gertrauden Hospital, Berlin, Germany. · MD Anderson Cancer Center Orlando, Orlando, FL, USA. · KarolinskaInstitutet and University Hospital, Stockholm, Sweden. · NN Petrov Research Institute of Oncology, St Petersburg, Russia. · University Women's Hospital, Kiel, Germany. · Jules Bordet Institute, Brussels, Belgium. · Frauenklinik des Universitätsklinikums, Erlangen, Germany. · Universitäts Frauenklinik, Rostock, Germany. · Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · Hospital of the Ludwig Maximilian University of Munich, Munich, Germany. · Pubmed 24529560
  • CR-UK/YCR Sheffield Cancer Research Centre, Weston Park Hospital, University of Sheffield, Sheffield, UK. Electronic address: · Edinburgh Cancer Research Centre, Western General Hospital, University of Edinburgh, Edinburgh, UK. · St James Institute of Oncology, University of Leeds, Leeds, UK. · Andrew Love Cancer Centre, Geelong, VIC, Australia. · CR-UK/YCR Sheffield Cancer Research Centre, Weston Park Hospital, University of Sheffield, Sheffield, UK. · CR-UK/YCR Sheffield Cancer Research Centre, Weston Park Hospital, University of Sheffield, Sheffield, UK; St James Institute of Oncology, University of Leeds, Leeds, UK. · University Hospital Galway, Galway, Ireland. · Institut Català d'Oncologia - IDIBELL. L'Hospitalet de Llobregat, Barcelona, Spain. · University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK. · Velindre Cancer Center, Whitchurch, Cardiff, UK. · Beatson West of Scotland Cancer Centre, Glasgow, UK. · Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK. · Pubmed 25035292
  • Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux, France · European Organisation for Research and Treatment of Cancer (EORTC), Brussels. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux, France. · Centre George-François Leclerc, Dijon. · Ensemble Hospitalier de L'Institut Curie, Hopital René Huguenin, St-Cloud. · Centre Paul Strauss, Strasbourg. · Centre Val D'Aurelle-Paul Lamarque, Montpellier, France. · Medical University, Gdansk, Poland. · Centre Henri Becquerel, Rouen, France. · Geneva University Hospital, Geneva Swiss Group for Clinical Cancer Research (SAKK), Bern. · Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. · Institute of Oncology, Ljubljana University Clinic Golnik, Golnik, Slovenia. · Institut de Cancérologie de L'Ouest (ICO), Centre René Gauducheau, Nantes Centre Paul Papin, Angers. · Centre Alexis Vautrin, Nancy, France. · Department of Clinical Sciences, Lund University, Lund Skåne Department of Oncology, Skåne University Hospital, Lund. · Swedish Breast Cancer Group (SweBCG), Stockholm Department of Oncology, Karolinska Institutet, Radiumhemmet and Karolinska University Hospital, Stockholm, Sweden. · Cancer Services, Edinburgh University Anglo-Celtic Cooperative Oncology Group (ACCOG), Edinburgh, UK. · Pubmed 24618153
  • Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK. · Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK. · Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK. · Leiden University Medical Center, Leiden, The Netherlands. · Department of Gynecological Oncology, University Hospital, Freiburg, Germany. · Department of Surgery, Athens University Medical School, Athens, Greece. · Oncology Center, St Augustinus, Antwerp, Belgium. · Department of Medical Oncology, Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands. · 1] Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK [2] Transformative Pathology, Ontario Institute for Cancer Research, Toronto, Canada. · Pubmed 25314051
  • MRC Centre for Reproductive Health, Queens Medical Research Institute, University of Edinburgh, Edinburgh, UK. · Edinburgh Breast Unit and Edinburgh University Cancer Research Centre, Western General Hospital, Edinburgh, UK. · MRC Centre for Reproductive Health, Queens Medical Research Institute, University of Edinburgh, Edinburgh, UK. Electronic address: · Pubmed 25027307
  • Edinburgh Cancer Centre, Western General Hospital, Edinburgh EH4 2XU, UK. Electronic address: · Pubmed 24333008
2013
  • University of Edinburgh and Cancer Services, NHS Lothian, Edinburgh, UK. · Pubmed 23932548
2010
2016
  • From the University of Texas M.D. Anderson Cancer Center, Houston (G.N.H.), and Texas Oncology-Baylor Charles A. Sammons Cancer Center and the U.S. Oncology Network, Dallas (J.O.) - all in Texas; Davidoff Center, Rabin Medical Center, Tel Aviv University, Tel Aviv (S.M.S.), and Sheba Medical Center, Ramat Gan (S.P.-S.) - both in Israel; the Sarah Cannon Research Institute (H.A.B., D.Y.), Vanderbilt-Ingram Cancer Center (C.L.A.), and Tennessee Oncology (D.Y.) - all in Nashville; National Cancer Center Singapore, Singapore (Y.-S.Y.); Netherlands Cancer Institute and BOOG Study Center, Amsterdam (G.S.S.); Institut de Cancérologie de l'Ouest/René Gauducheau, Saint-Herblain (M.C.), Institut Gustave Roussy, Université Paris Sud, Villejuif (F.A.), University Hospital of Besançon, Besançon (C.V.), and Centre Léon Bérard, Lyon (T.B.) - all in France; Duke University Medical Center, Durham, NC (K.L.B.); Dana-Farber Cancer Institute, Boston (E.P.W.); University of Ulm, Ulm (W.J.), Onkologische Praxis, Velbert (A.N.), University of Tübingen, Tübingen (E.-M.G.), and Joint Practice for Interdisciplinary Oncology and Hematology, Freiburg (N.M.) - all in Germany; Tom Baker Cancer Centre, Calgary, AB, Canada (S.V.); University of Padua and Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy (P.C.); Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh (D.A.C.); Masaryk Memorial Cancer Institute, Brno, Czech Republic (K.P.); Florida Cancer Specialists-Sarah Cannon Research Institute, Fort Myers (L.L.H.); Breast Cancer Research Centre-Western Australia and Curtin University, Perth, Australia (A.C.); Department of Oncology, Vejle Hospital, Vejle, Denmark (E.J.); Arkhangelsk Clinical Oncology Dispensary, Arkhangelsk, Russia (O.B.); Hospital Universitario Virgen de la Victoria, Institute of Biomedical Research in Málaga, Málaga, Spain (E.A.); Oslo University Hospital, Oslo (E.W.); Virginia Cancer Specialists, Arlington (A.M.F.); Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan (L.-M.T.); Rainier Hematology-Oncology, Northwest Medical Specialties, Puyallup, WA (S.B.); Novartis Pharmaceuticals, East Hanover, NJ (F.X., M.M., C.G., S.H.); and Novartis Pharma, Basel, Switzerland (F.S.). · Pubmed 27717303
  • Ontario Institute for Cancer Research, Toronto, Ontario, Canada (JMSB, JB); University of Toronto, Toronto, Canada (JMSB); University of Edinburgh, Edinburgh, UK (JMSB, CC, MSS, PSH, DAC); Warwick Clinical Trials Unit, University of Warwick, Coventry, UK (AM, JAD, AC); University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK (CJP); University of Cambridge Department of Oncology and NIHR Cambridge Biomedical Research Centre, Cambridge, UK (HME); Cancer Research UK Institute for Cancer Studies, University of Birmingham, Birmingham, UK (DWR); University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK (IRM, PC); University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK (AF); University of Alberta, Edmonton, AB, Canada (CM); Kings College London, Guy's Hospital, London, UK (SEP); Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK (LHD); Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, Middlesex, UK (AM); National Institute for Health Research University College London Hospitals Biomedical Research Centre, London, UK (RCS). · Ontario Institute for Cancer Research, Toronto, Ontario, Canada (JMSB, JB); University of Toronto, Toronto, Canada (JMSB); University of Edinburgh, Edinburgh, UK (JMSB, CC, MSS, PSH, DAC); Warwick Clinical Trials Unit, University of Warwick, Coventry, UK (AM, JAD, AC); University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK (CJP); University of Cambridge Department of Oncology and NIHR Cambridge Biomedical Research Centre, Cambridge, UK (HME); Cancer Research UK Institute for Cancer Studies, University of Birmingham, Birmingham, UK (DWR); University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK (IRM, PC); University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK (AF); University of Alberta, Edmonton, AB, Canada (CM); Kings College London, Guy's Hospital, London, UK (SEP); Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK (LHD); Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, Middlesex, UK (AM); National Institute for Health Research University College London Hospitals Biomedical Research Centre, London, UK (RCS). · Pubmed 27130929
  • Chee Khoon Lee, Lucy Davies, Val J. Gebski, Sarah J. Lord, Ian Marschner, and John Simes, University of Sydney; Sarah J. Lord, University of Notre Dame; Ian Marschner, Macquarie University; Paul de Souza, University of Western Sydney, Sydney, New South Wales; Sherene Loi, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Angelo Di Leo, Hospital of Prato, Istituto Toscano Tumori, Italy; Stephen Johnston, Royal Marsden Hospital, London; David Cameron, University of Edinburgh, Edinburgh, United Kingdom; Charles Geyer Jr, Virginia Commonwealth University Massey Cancer Center, Richmond, VA; Michael F. Press, University of Southern California, Los Angeles, CA; and Catherine Ellis, GlaxoSmithKline, Collegeville, PA. · Chee Khoon Lee, Lucy Davies, Val J. Gebski, Sarah J. Lord, Ian Marschner, and John Simes, University of Sydney; Sarah J. Lord, University of Notre Dame; Ian Marschner, Macquarie University; Paul de Souza, University of Western Sydney, Sydney, New South Wales; Sherene Loi, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Angelo Di Leo, Hospital of Prato, Istituto Toscano Tumori, Italy; Stephen Johnston, Royal Marsden Hospital, London; David Cameron, University of Edinburgh, Edinburgh, United Kingdom; Charles Geyer Jr, Virginia Commonwealth University Massey Cancer Center, Richmond, VA; Michael F. Press, University of Southern California, Los Angeles, CA; and Catherine Ellis, GlaxoSmithKline, Collegeville, PA. · Pubmed 26811533
2014
  • Evandro de Azambuja and Martine J. Piccart-Genhart, Institut Jules Bordet; Evandro de Azambuja, Breast European Adjuvant Study Team; Martine J. Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium; Marion J. Procter and Dominique Agbor-Tarh, Frontier Science Scotland, Kincraig, Kingussie; David A. Cameron, University of Edinburgh and Western General Hospital, Edinburgh; Ian E. Smith, Royal Marsden Hospital and the Institute of Cancer Research; Mitch Dowsett, the Royal Marsden National Health Service Trust, London, United Kingdom; Dirk J. van Veldhuisen, University of Groningen, Groningen, the Netherlands; Otto Metzger-Filho and Richard D. Gelber, Dana-Farber Cancer Institute, Boston, MA; Jutta Steinseifer, F. Hoffmann-La Roche, Basel; Thomas M. Suter, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, Bern, Switzerland; Michael Untch, HELIOS Klinikum Berlin, Buch; Christian Jackisch, Klinikum Offenbach, Offenbach, Germany; Luca Gianni, San Raffaele Institute, Milan, Italy; Jose Baselga, Memorial Sloan Kettering Cancer Center, New York, NY; Richard Bell, Andrew Love Cancer Centre, Geelong Hospital, Geelong, Australia; and Brian Leyland-Jones, Edith Sanford Breast Cancer Research Institute, Sioux Falls, SD. · Evandro de Azambuja and Martine J. Piccart-Genhart, Institut Jules Bordet; Evandro de Azambuja, Breast European Adjuvant Study Team; Martine J. Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium; Marion J. Procter and Dominique Agbor-Tarh, Frontier Science Scotland, Kincraig, Kingussie; David A. Cameron, University of Edinburgh and Western General Hospital, Edinburgh; Ian E. Smith, Royal Marsden Hospital and the Institute of Cancer Research; Mitch Dowsett, the Royal Marsden National Health Service Trust, London, United Kingdom; Dirk J. van Veldhuisen, University of Groningen, Groningen, the Netherlands; Otto Metzger-Filho and Richard D. Gelber, Dana-Farber Cancer Institute, Boston, MA; Jutta Steinseifer, F. Hoffmann-La Roche, Basel; Thomas M. Suter, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, Bern, Switzerland; Michael Untch, HELIOS Klinikum Berlin, Buch; Christian Jackisch, Klinikum Offenbach, Offenbach, Germany; Luca Gianni, San Raffaele Institute, Milan, Italy; Jose Baselga, Memorial Sloan Kettering Cancer Center, New York, NY; Richard Bell, Andrew Love Cancer Centre, Geelong Hospital, Geelong, Australia; and Brian Leyland-Jones, Edith Sanford Breast Cancer Research Institute, Sioux Falls, SD. · Pubmed 24912899
  • Department of Surgery and GROW School for Oncology and Developmental Biology (MM, MLS), Department of Surgery and Radiology (LMvR), Department of Medical Oncology, GROW School for Oncology and Developmental Biology (VCGTH), and Department of Epidemiology and GROW School for Oncology and Developmental Biology (ACV), Maastricht University Medical Center, Maastricht, the Netherlands; Department of Surgery, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands (LJAS); Division of Medical Oncology, Luzerner Kantonsspital, Lucerne, Switzerland (SA); Edinburgh Cancer Research Centre, University of Edinburgh and NHS Lothian (DAC), Edinburgh Breast Unit (JMD), Western General Hospital, Edinburgh, UK; Cedars-Sinai Medical Center, Los Angeles, CA (AEG); Rutgers Cancer Institute of New Jersey, New Brunswick, NJ (BGH); Mater Centre Radiation Oncology Service, Princess Alexandra Hospital, Brisbane, Australia (BEH); Breast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center and Professor of Medicine, Weill Cornell Medical College, New York, NY (CAH); University of Arkansas for Medical Sciences, Winthrop P. Rockefeller Cancer Institute, Little Rock, AR (VSK); Flinders Centre for Innovation in Cancer, Flinders University, Adelaide, Australia (BK); Interdisciplinary Breast Centre, Department of Gynaecology and Obstetrics, Klinikum Esslingen, Germany (TK); University of Miami Miller School of Medicine, Miami, FL (MEL); Radiation Oncology (BDS) and Department of Surgical Oncology, Division of Surgery (AL), University of Texas/MD Anderson Cancer Center, Houston, TX; Institut Jules Bordet, Université Libre de Bruxelles, Head of Medicine Department, Brussels, Belgium (MP); Surgery, University Medical Center, Leiden, the Netherlands (CJHvdV); Breast Service, Memorial Sloan-Kettering Cancer Center, Evelyn Lauder Breast Center, New York, NY(KJVZ); Antwerp University Hospital, Department of Medical Oncology, Edegem, Belgium (JBV); Department of Pathology, European Institute of · Pubmed 25381395
2013
  • Division of Pathology, Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road South, Edinburgh, EH4 2XU, UK. · Pubmed 23984893
  • From the Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Edinburgh Cancer Research UK Centre, University of Edinburgh, Edinburgh, United Kingdom; and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Pubmed 23714441
  • MRC Centre for Reproductive Health, University of Edinburgh, Queens Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, UK. Electronic address: · Pubmed 23968732
2012
  • Endocrine Cancer Group, Edinburgh Cancer Research UK Centre, MRC IGMM, University of Edinburgh, Crewe Road South, Edinburgh EH4 2XR, UK. · Pubmed 22644297
  • Edinburgh Cancer Centre, Western General Hospital, Edinburgh, United Kingdom. · Pubmed 22197227
  • Edinburgh Breakthrough Breast Cancer Unit, Edinburgh Cancer Research Centre, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK. · Pubmed 21638049
  • Breakthrough Breast Cancer, Edinburgh Cancer Research Centre, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK. · Pubmed 21390497
2011
  • Division of Reproduction and Developmental Sciences and Medical Research Council Human Reproductive Sciences Unit, Centre for Reproductive Biology, University of Edinburgh, Edinburgh EH16 4TJ, United Kingdom. · Pubmed 21325458
2010
  • Endocrine Cancer Group, Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. · Pubmed 20676126
  • Endocrine Cancer Group, Edinburgh Cancer Research Centre, Edinburgh University, Carrington Crescent, Edinburgh EH4 2XU, UK. · Pubmed 20615243
  • CRUK Cancer Research Centre and Academic Breast Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road South, Edinburgh, UK. · Pubmed 20569502
  • Endocrine Cancer Group, Edinburgh University, Edinburgh, UK. · Pubmed 20079691
2009
  • Edinburgh Breast Unit, Western General Hospital, Edinburgh, UK. · Pubmed 19845790
Probable:    University of London      
2017
  • Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, UK. Electronic address: · Clinical Trials Research Unit, University of Leeds, Leeds, UK. · IMIM-CIBERONC, Barcelona; Medical Oncology Department, Hospital del Mar, Barcelona, Spain; Pompeu Fabra University, Barcelona, Spain. · Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Deakin University, Geelong, VIC, Australia. · Cancer Research UK Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK. · St James Institute of Oncology, St James Hospital, Leeds, UK. · Inbiomotion, Barcelona, Spain. · Fundación Jiménez Díaz, Madrid, Spain; CIBERONC, Madrid, Spain. · IMIM-CIBERONC, Barcelona; Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. · Pubmed 29037984
  • Cancer Research UK Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK. Electronic address: · ICR-CTSU, Division of Clinical Studies, Institute of Cancer Research, London, UK. · Department of Oncology, Beatson Hospital, Glasgow, UK. · St James' Institute of Oncology, University of Leeds, Leeds, UK. · Department of Oncology, Weston Park Hospital, Sheffield, UK. · Department of Diagnostic Development, Ontario Institute for Cancer Research, Toronto, ON, Canada. · Department of Oncology, Shrewsbury & Telford Hospitals NHS Trust, Shrewsbury, UK. · Department of Oncology, Singleton Hospital, Swansea, UK. · Department of Oncology, Royal Sussex County Hospital, Brighton, UK. · Department of Oncology, Royal Stoke University Hospital, Stoke-on-Trent, UK. · Department of Oncology, Addenbrooke's Hospital, Cambridge, UK. · Department of Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK. · Cancer Research UK Clinical Trials Unit, University of Birmingham, UK. · Clinical Trials Research Unit (CTRU), University of Leeds, Leeds, UK. · Department of Oncology, Royal Surrey County Hospital, Guildford, UK. · Department of Oncology, Southampton General Hospital, Southampton, UK. · Cancer Clinical Trials Unit Scotland (CaCTUS), Glasgow, UK. · Department of Oncology, NIHR University College London Hospitals Biomedical Research Centre, London, UK. · Department of Oncology, Northern Centre for Cancer Care, Freeman Hospital, Newcastle, UK. · Department of Oncology, Christie Hospital, Manchester, UK. · Department of Oncology, Velindre NHS Trust, Cardiff, UK. · Pubmed 28600210
  • Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge, UK. Electronic address: · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Leeds Institute for Clinical Trials Research, University of Leeds, Leeds, UK. · Cancer Research UK Clinical Trials Unit (CRCTU), Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. · Scottish Clinical Trials Research Unit, NHS Natio nal Services Scotland, Edinburgh, UK. · The Christie NHS Foundation Trust, Manchester, UK. · Department of Oncology, Shrewsbury & Telford Hospitals NHS Trust, Shrewsbury, UK. · Department of Oncology, Clatterbridge Cancer Centre, Wirral, UK. · Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK. · Department of Oncology, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Exeter Oncology Centre, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK. · Department of Oncology, Poole Hospital, Poole Hospital NHS Foundation Trust/Bournemouth University, Poole, Dorset, UK. · Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Edith Cavell Campus, Peterborough City Hospital, Peterborough and Stamford Hospitals NHS Foundation Trust, Peterborough, UK. · Cancer Research UK Edinburgh Centre, MRC Institute of Genetics & Molecular Medicine, University of Edinburgh, Edinburgh, UK. · Institute of Oncology, St James's University Hospital, Leeds Teaching Hospital NHS Trust, Leeds, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge UK; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge, UK. · NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Department of Histopathology, Cambridge, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge, UK. · Cancer Clinical Trials Unit (CaCTUS), Beatson West of Scotland Cancer Centre, Glasgow, UK. · Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland. · Cancer Trials Ireland (formerly ICORG), Dublin, Ireland. · Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, UK. · Department of Surgery and Cancer, Charing Cross Hospital, Imperial College London, London, UK. · Celgene, Research and Development, San Diego, CA, USA. · NIHR/CRUK Christie Clinical Research Facility, Manchester, UK. · Arden Cancer Research Centre, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK. · Pubmed 28479233
2015
  • University of Edinburgh Cancer Research Centre, Institute of Genetics and Molecular Medicine, Western General Hospital, Edinburgh EH4 2XU, UK. Electronic address: · Pubmed 26363986
2016
  • From the University of Texas M.D. Anderson Cancer Center, Houston (G.N.H.), and Texas Oncology-Baylor Charles A. Sammons Cancer Center and the U.S. Oncology Network, Dallas (J.O.) - all in Texas; Davidoff Center, Rabin Medical Center, Tel Aviv University, Tel Aviv (S.M.S.), and Sheba Medical Center, Ramat Gan (S.P.-S.) - both in Israel; the Sarah Cannon Research Institute (H.A.B., D.Y.), Vanderbilt-Ingram Cancer Center (C.L.A.), and Tennessee Oncology (D.Y.) - all in Nashville; National Cancer Center Singapore, Singapore (Y.-S.Y.); Netherlands Cancer Institute and BOOG Study Center, Amsterdam (G.S.S.); Institut de Cancérologie de l'Ouest/René Gauducheau, Saint-Herblain (M.C.), Institut Gustave Roussy, Université Paris Sud, Villejuif (F.A.), University Hospital of Besançon, Besançon (C.V.), and Centre Léon Bérard, Lyon (T.B.) - all in France; Duke University Medical Center, Durham, NC (K.L.B.); Dana-Farber Cancer Institute, Boston (E.P.W.); University of Ulm, Ulm (W.J.), Onkologische Praxis, Velbert (A.N.), University of Tübingen, Tübingen (E.-M.G.), and Joint Practice for Interdisciplinary Oncology and Hematology, Freiburg (N.M.) - all in Germany; Tom Baker Cancer Centre, Calgary, AB, Canada (S.V.); University of Padua and Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy (P.C.); Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh (D.A.C.); Masaryk Memorial Cancer Institute, Brno, Czech Republic (K.P.); Florida Cancer Specialists-Sarah Cannon Research Institute, Fort Myers (L.L.H.); Breast Cancer Research Centre-Western Australia and Curtin University, Perth, Australia (A.C.); Department of Oncology, Vejle Hospital, Vejle, Denmark (E.J.); Arkhangelsk Clinical Oncology Dispensary, Arkhangelsk, Russia (O.B.); Hospital Universitario Virgen de la Victoria, Institute of Biomedical Research in Málaga, Málaga, Spain (E.A.); Oslo University Hospital, Oslo (E.W.); Virginia Cancer Specialists, Arlington (A.M.F.); Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan (L.-M.T.); Rainier Hematology-Oncology, Northwest Medical Specialties, Puyallup, WA (S.B.); Novartis Pharmaceuticals, East Hanover, NJ (F.X., M.M., C.G., S.H.); and Novartis Pharma, Basel, Switzerland (F.S.). · Pubmed 27717303
  • Ontario Institute for Cancer Research, Toronto, Ontario, Canada (JMSB, JB); University of Toronto, Toronto, Canada (JMSB); University of Edinburgh, Edinburgh, UK (JMSB, CC, MSS, PSH, DAC); Warwick Clinical Trials Unit, University of Warwick, Coventry, UK (AM, JAD, AC); University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK (CJP); University of Cambridge Department of Oncology and NIHR Cambridge Biomedical Research Centre, Cambridge, UK (HME); Cancer Research UK Institute for Cancer Studies, University of Birmingham, Birmingham, UK (DWR); University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK (IRM, PC); University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK (AF); University of Alberta, Edmonton, AB, Canada (CM); Kings College London, Guy's Hospital, London, UK (SEP); Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK (LHD); Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, Middlesex, UK (AM); National Institute for Health Research University College London Hospitals Biomedical Research Centre, London, UK (RCS). · Ontario Institute for Cancer Research, Toronto, Ontario, Canada (JMSB, JB); University of Toronto, Toronto, Canada (JMSB); University of Edinburgh, Edinburgh, UK (JMSB, CC, MSS, PSH, DAC); Warwick Clinical Trials Unit, University of Warwick, Coventry, UK (AM, JAD, AC); University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK (CJP); University of Cambridge Department of Oncology and NIHR Cambridge Biomedical Research Centre, Cambridge, UK (HME); Cancer Research UK Institute for Cancer Studies, University of Birmingham, Birmingham, UK (DWR); University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK (IRM, PC); University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK (AF); University of Alberta, Edmonton, AB, Canada (CM); Kings College London, Guy's Hospital, London, UK (SEP); Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK (LHD); Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, Middlesex, UK (AM); National Institute for Health Research University College London Hospitals Biomedical Research Centre, London, UK (RCS). · Pubmed 27130929
2014
  • Evandro de Azambuja and Martine J. Piccart-Genhart, Institut Jules Bordet; Evandro de Azambuja, Breast European Adjuvant Study Team; Martine J. Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium; Marion J. Procter and Dominique Agbor-Tarh, Frontier Science Scotland, Kincraig, Kingussie; David A. Cameron, University of Edinburgh and Western General Hospital, Edinburgh; Ian E. Smith, Royal Marsden Hospital and the Institute of Cancer Research; Mitch Dowsett, the Royal Marsden National Health Service Trust, London, United Kingdom; Dirk J. van Veldhuisen, University of Groningen, Groningen, the Netherlands; Otto Metzger-Filho and Richard D. Gelber, Dana-Farber Cancer Institute, Boston, MA; Jutta Steinseifer, F. Hoffmann-La Roche, Basel; Thomas M. Suter, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, Bern, Switzerland; Michael Untch, HELIOS Klinikum Berlin, Buch; Christian Jackisch, Klinikum Offenbach, Offenbach, Germany; Luca Gianni, San Raffaele Institute, Milan, Italy; Jose Baselga, Memorial Sloan Kettering Cancer Center, New York, NY; Richard Bell, Andrew Love Cancer Centre, Geelong Hospital, Geelong, Australia; and Brian Leyland-Jones, Edith Sanford Breast Cancer Research Institute, Sioux Falls, SD. · Evandro de Azambuja and Martine J. Piccart-Genhart, Institut Jules Bordet; Evandro de Azambuja, Breast European Adjuvant Study Team; Martine J. Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium; Marion J. Procter and Dominique Agbor-Tarh, Frontier Science Scotland, Kincraig, Kingussie; David A. Cameron, University of Edinburgh and Western General Hospital, Edinburgh; Ian E. Smith, Royal Marsden Hospital and the Institute of Cancer Research; Mitch Dowsett, the Royal Marsden National Health Service Trust, London, United Kingdom; Dirk J. van Veldhuisen, University of Groningen, Groningen, the Netherlands; Otto Metzger-Filho and Richard D. Gelber, Dana-Farber Cancer Institute, Boston, MA; Jutta Steinseifer, F. Hoffmann-La Roche, Basel; Thomas M. Suter, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, Bern, Switzerland; Michael Untch, HELIOS Klinikum Berlin, Buch; Christian Jackisch, Klinikum Offenbach, Offenbach, Germany; Luca Gianni, San Raffaele Institute, Milan, Italy; Jose Baselga, Memorial Sloan Kettering Cancer Center, New York, NY; Richard Bell, Andrew Love Cancer Centre, Geelong Hospital, Geelong, Australia; and Brian Leyland-Jones, Edith Sanford Breast Cancer Research Institute, Sioux Falls, SD. · Pubmed 24912899
  • Department of Surgery and GROW School for Oncology and Developmental Biology (MM, MLS), Department of Surgery and Radiology (LMvR), Department of Medical Oncology, GROW School for Oncology and Developmental Biology (VCGTH), and Department of Epidemiology and GROW School for Oncology and Developmental Biology (ACV), Maastricht University Medical Center, Maastricht, the Netherlands; Department of Surgery, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands (LJAS); Division of Medical Oncology, Luzerner Kantonsspital, Lucerne, Switzerland (SA); Edinburgh Cancer Research Centre, University of Edinburgh and NHS Lothian (DAC), Edinburgh Breast Unit (JMD), Western General Hospital, Edinburgh, UK; Cedars-Sinai Medical Center, Los Angeles, CA (AEG); Rutgers Cancer Institute of New Jersey, New Brunswick, NJ (BGH); Mater Centre Radiation Oncology Service, Princess Alexandra Hospital, Brisbane, Australia (BEH); Breast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center and Professor of Medicine, Weill Cornell Medical College, New York, NY (CAH); University of Arkansas for Medical Sciences, Winthrop P. Rockefeller Cancer Institute, Little Rock, AR (VSK); Flinders Centre for Innovation in Cancer, Flinders University, Adelaide, Australia (BK); Interdisciplinary Breast Centre, Department of Gynaecology and Obstetrics, Klinikum Esslingen, Germany (TK); University of Miami Miller School of Medicine, Miami, FL (MEL); Radiation Oncology (BDS) and Department of Surgical Oncology, Division of Surgery (AL), University of Texas/MD Anderson Cancer Center, Houston, TX; Institut Jules Bordet, Université Libre de Bruxelles, Head of Medicine Department, Brussels, Belgium (MP); Surgery, University Medical Center, Leiden, the Netherlands (CJHvdV); Breast Service, Memorial Sloan-Kettering Cancer Center, Evelyn Lauder Breast Center, New York, NY(KJVZ); Antwerp University Hospital, Department of Medical Oncology, Edegem, Belgium (JBV); Department of Pathology, European Institute of · Pubmed 25381395
2013
  • From the Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Edinburgh Cancer Research UK Centre, University of Edinburgh, Edinburgh, United Kingdom; and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Pubmed 23714441
2010
  • Department of Medical Oncology, Guy's and St Thomas' Hospital, Guy's and St Thomas' Foundation Trust and King's College London Biomedical Research Centre, 4th Floor, Bermondsey Wing, Great Maze Pond, London SE1 9RT, UK. · Pubmed 20559708
  • CRUK Cancer Research Centre and Academic Breast Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road South, Edinburgh, UK. · Pubmed 20569502
Probable:    Miscellaneous institutions in Edinburgh      
2017
  • Indiana University School of Medicine, Indianapolis, Indiana. · Indiana University School of Medicine, Indianapolis, Indiana. · Dana Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, Massachusetts. · Albert Einstein University, Montefiore Medical Center, Bronx, New York. · University of Pittsburgh Cancer Center, Pittsburgh, Pennsylvania. · Edinburgh Cancer Research Centre, Edinburgh, United Kingdom. · Swiss Cardiovascular Center, Bern University Hospital, Inselspital, Bern, Switzerland. · Stanford University School of Medicine, Stanford, California. · Pubmed 27993963
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 98 total) written by David Allan Cameron about Breast Neoplasms:

  • Concerns about cardiotoxicity in the HERA trial - Authors' reply. 2018
  • Effect of MAF amplification on treatment outcomes with adjuvant zoledronic acid in early breast cancer: a secondary analysis of the international, open-label, randomised, controlled, phase 3 AZURE (BIG 01/04) trial. 2017
  • Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial. 2017
  • Factors predictive of locoregional recurrence following neoadjuvant chemotherapy in patients with large operable or locally advanced breast cancer: An analysis of the EORTC 10994/BIG 1-00 study. 2017
  • Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial. 2017
  • Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-label, randomised, phase 3 trial. 2017
  • Cardiac safety, efficacy, and correlation of serial serum HER2-extracellular domain shed antigen measurement with the outcome of the combined trastuzumab plus CMF in women with HER2-positive metastatic breast cancer: results from the EORTC 10995 phase II study. 2017
  • 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial. 2017
  • The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer. 2017
  • Correlation between severe infection and breast cancer metastases in the EORTC 10994/BIG 1-00 trial: Investigating innate immunity as a tumour suppressor in breast cancer. 2017
Show List of Full Article Records
Google Searches

Learn more about David Allan Cameron using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Edinburgh
University of London
Miscellaneous institutions in Edinburgh
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Edinburgh
2018
  • Edinburgh Cancer Centre, Western General Hospital, Edinburgh EH4 2XU, UK. Electronic address: · Edinburgh Cancer Centre, Western General Hospital, Edinburgh EH4 2XU, UK. · Pubmed 29303722
2017
  • Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, UK. Electronic address: · Clinical Trials Research Unit, University of Leeds, Leeds, UK. · IMIM-CIBERONC, Barcelona; Medical Oncology Department, Hospital del Mar, Barcelona, Spain; Pompeu Fabra University, Barcelona, Spain. · Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Deakin University, Geelong, VIC, Australia. · Cancer Research UK Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK. · St James Institute of Oncology, St James Hospital, Leeds, UK. · Inbiomotion, Barcelona, Spain. · Fundación Jiménez Díaz, Madrid, Spain; CIBERONC, Madrid, Spain. · IMIM-CIBERONC, Barcelona; Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. · Pubmed 29037984
  • Cancer Research UK Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK. Electronic address: · ICR-CTSU, Division of Clinical Studies, Institute of Cancer Research, London, UK. · Department of Oncology, Beatson Hospital, Glasgow, UK. · St James' Institute of Oncology, University of Leeds, Leeds, UK. · Department of Oncology, Weston Park Hospital, Sheffield, UK. · Department of Diagnostic Development, Ontario Institute for Cancer Research, Toronto, ON, Canada. · Department of Oncology, Shrewsbury & Telford Hospitals NHS Trust, Shrewsbury, UK. · Department of Oncology, Singleton Hospital, Swansea, UK. · Department of Oncology, Royal Sussex County Hospital, Brighton, UK. · Department of Oncology, Royal Stoke University Hospital, Stoke-on-Trent, UK. · Department of Oncology, Addenbrooke's Hospital, Cambridge, UK. · Department of Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK. · Cancer Research UK Clinical Trials Unit, University of Birmingham, UK. · Clinical Trials Research Unit (CTRU), University of Leeds, Leeds, UK. · Department of Oncology, Royal Surrey County Hospital, Guildford, UK. · Department of Oncology, Southampton General Hospital, Southampton, UK. · Cancer Clinical Trials Unit Scotland (CaCTUS), Glasgow, UK. · Department of Oncology, NIHR University College London Hospitals Biomedical Research Centre, London, UK. · Department of Oncology, Northern Centre for Cancer Care, Freeman Hospital, Newcastle, UK. · Department of Oncology, Christie Hospital, Manchester, UK. · Department of Oncology, Velindre NHS Trust, Cardiff, UK. · Pubmed 28600210
  • Department of Radiotherapy, Institut Bergonié Unicancer, Bordeaux, France. · EORTC, Statistics Department, Avenue Emmanuel Mounier 83b11, 1200 Brussels, Belgium. · Western General Hospital, Edinburgh Cancer Centre, Crewe Road South, GB Edinburgh EH4 2XU, United Kingdom. · Department of Medical Oncology, Institut Bergonié Unicancer, Univ. Bordeaux, INSERM U1218, INSERM CIC1401 Bordeaux, France. Electronic address: · Pubmed 28527420
  • Li Ka Shing Centre, Cancer Research UK Cambridge Institute. · Department of Pathology. · Institute of Astronomy, University of Cambridge, Cambridge. · Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge. · Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Ontario Institute for Cancer Research, Toronto, Canada. · Pubmed 28525534
  • Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge, UK. Electronic address: · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Leeds Institute for Clinical Trials Research, University of Leeds, Leeds, UK. · Cancer Research UK Clinical Trials Unit (CRCTU), Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. · Scottish Clinical Trials Research Unit, NHS Natio nal Services Scotland, Edinburgh, UK. · The Christie NHS Foundation Trust, Manchester, UK. · Department of Oncology, Shrewsbury & Telford Hospitals NHS Trust, Shrewsbury, UK. · Department of Oncology, Clatterbridge Cancer Centre, Wirral, UK. · Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK. · Department of Oncology, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Exeter Oncology Centre, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK. · Department of Oncology, Poole Hospital, Poole Hospital NHS Foundation Trust/Bournemouth University, Poole, Dorset, UK. · Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Edith Cavell Campus, Peterborough City Hospital, Peterborough and Stamford Hospitals NHS Foundation Trust, Peterborough, UK. · Cancer Research UK Edinburgh Centre, MRC Institute of Genetics & Molecular Medicine, University of Edinburgh, Edinburgh, UK. · Institute of Oncology, St James's University Hospital, Leeds Teaching Hospital NHS Trust, Leeds, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge UK; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge, UK. · NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Department of Histopathology, Cambridge, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge, UK. · Cancer Clinical Trials Unit (CaCTUS), Beatson West of Scotland Cancer Centre, Glasgow, UK. · Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland. · Cancer Trials Ireland (formerly ICORG), Dublin, Ireland. · Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, UK. · Department of Surgery and Cancer, Charing Cross Hospital, Imperial College London, London, UK. · Celgene, Research and Development, San Diego, CA, USA. · NIHR/CRUK Christie Clinical Research Facility, Manchester, UK. · Arden Cancer Research Centre, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK. · Pubmed 28479233
  • EORTC Headquarters, Brussels, Belgium. · EORTC Headquarters, Brussels, Belgium. · Department of Medical Oncology, National Cancer Institute- Cairo University, Cairo, Egypt. · Department of Medical Oncology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands. · Department of Medical Oncology, Antwerp University Hospital, Edegem, Belgium. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Ontario Institute for Cancer Research, Toronto, Ontario, Canada. · University of Edinburgh Cancer Research Center, Western General Hospital, Edinburgh, UK. · Department of Medical Oncology, New Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · University of Edinburgh Cancer Research Center, Western General Hospital, Edinburgh, UK. · Pubmed 28324265
  • University of Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. Electronic address: · Department of Medicine, Université Libre de Bruxelles, Brussels, Belgium. · BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA, USA. · Frontier Science Scotland Ltd, Kincraig, Kingussie, UK. · European Institute of Oncology, Milan, Italy. · Medical Oncology Clinic, Université Libre de Bruxelles, Brussels, Belgium. · Clinical Oncology, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. · Helios Klinikum Berlin Buch, Multidisciplinary Breast Cancer Center, Berlin, Germany. · Breast Unit, Royal Marsden Hospital, and The Institute of Cancer Research, London, UK. · Department of Medical Oncology, San Raffaele Hospital, Scientific Institute, Milan, Italy. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · F Hoffmann-La Roche, Basel, Switzerland. · Avera Cancer Institute Center for Precision Oncology, Sioux Falls, SD, USA. · Deakin University, Waurn Ponds, VIC, Australia. · Department of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany. · Pubmed 28215665
  • Department of Pathology, Western General Hospital, Edinburgh, EH4 2XU, UK. · Leeds Institute of Cancer and Pathology, St James's University Hospital, Leeds, LS9 7TF, UK. · Department of Radiation Oncology, Netherlands Cancer Institute, Postbus 90203, 1006 BE, Amsterdam, Netherlands. · Academic Medical Center, University of Amsterdam, 1105 AZ, Amsterdam, Netherlands. · Scottish Clinical Trials Research Unit, NHS National Services Scotland, Edinburgh, EH12 9EB, UK. · Centre of Population Health Sciences, Edinburgh University Medical School, Edinburgh, EH8 9AG, UK. · Edinburgh Cancer Centre, Western General Hospital, Edinburgh, EH4 2XU, UK. · Ontario Institute for Cancer Research, Toronto, ON, M5G0A3, Canada. · Beatson Oncology Centre, Gartnavel Campus, Glasgow, G12 0YN, UK. · Pubmed 28190252
  • EORTC, Statistics Department, Avenue Emmanuel Mounier 83b11, 1200 Brussels, Belgium. Electronic address: · EORTC, Medical Department, Avenue Emmanuel Mounier 83b11, 1200 Brussels, Belgium. Electronic address: · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: · Department of Medical Oncology, Institut Bergonié Unicancer, INSERM CIC1401, Bordeaux, France. Electronic address: · Western General Hospital, Edinburgh Cancer Centre, Crewe Road South, GB Edinburgh EH4 2XU, UK. Electronic address: · EORTC, Statistics Department, Avenue Emmanuel Mounier 83b11, 1200 Brussels, Belgium. Electronic address: · Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Australia. Electronic address: · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: · Pubmed 28027521
  • Mount Vernon Cancer Centre, Rickmansworth Road, Northwood, London, HA6 2RN, UK. Electronic address: · University of Edinburgh and Cancer Services, NHS Lothian, Western General Hospital, Crewe Road South, Edinburgh, EH4 2XU, UK. · Oncology Department, Dnipropetrovsk Medical Academy, Multiprofile Clinical Hospital, #449102, Blizhnaya Str, Dnipropetrovsk, Ukraine. · NN Blokhin Cancer Centre, Kashirskoye Schosse 23, Moscow, 115478, Russia. · Centro Hemato Oncológico Panama, Marbella Edificio Royal Center, 5to. Piso Torre B, Panama City, Panama. · Medical Oncology Department, National Oncology Institute, Gorgas & Juan de Arco Street, Ancon, PO Box 0816-04433, Panama City, Panama. · Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, South Korea. · Oncology and Haematology Service, Grand Hôpital de Charleroi, Grand Rue 3, 6000, Charleroi, Belgium. · Lviv State Oncological Regional Treatment and Diagnostic Center, 2a Hashek Str, Lviv, 79031, Ukraine. · Sarah Cannon Research Institute and Tennessee Oncology, PLCC, 3322 West End Avenue, Suite 900TN, Nashville, TN, 37203, USA. · Department of Surgery, Breast Oncology, National Hospital Organization Osaka National Hospital, 2-1-14, Hoenzaka, Chuou-ku, Osaka, 540-0006, Japan. · Center for Breast Cancer, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do, 10408, South Korea. · Virginia Cancer Specialists Research Institute, US Oncology, 1635 N. George Mason, Suite 170, Arlington, VA, 22205, USA. · Biostatistics Oncology, Pharma Development, F. Hoffmann-La Roche, Building 670, Malzgasse 30, 4070 Basel, Switzerland. · Global Development BioOncology, Genentech Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. · Baylor Charles A. Sammons Cancer Center, US Oncology and Texas Oncology, 3410 Worth Street, Suite 400, Dallas, TX, 75246, USA. · Pubmed 27817944
  • Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK; Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK. Electronic address: · Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK. · Department of Clinical Oncology, Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, Northwood, UK. · Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK. · Ontario Institute for Cancer Research, Toronto, Ontario, Canada. · Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK. · Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow, UK. · Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. · Independent Cancer Patients' Voice, London, UK. · National Institute for Health Research, University College London Hospitals Biomedical Research Centre, London, UK. · University of Alberta, Edmonton, Alberta, Canada. · Pubmed 29241890
  • Department of Pathology, Western General Hospital, Edinburgh, UK. · NIHR Cambridge Biomedical Research Centre, Addenbrookes Hospital, Cambridge, UK. · Cambridge Breast Cancer Research Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Department of Histopathology, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Cambridge Clinical Trials Unit-Cancer Theme, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, King's Lynn, UK. · University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK. · Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Peterborough City Hospital, Edith Cavell Campus, Peterborough, UK. · Nottingham University Hospital (City Campus), Nottingham, UK. · West Middlesex University Hospital, Isleworth, UK. · Poole Hospital NHS Foundation Trust, Poole, UK. · Bournemouth University, Poole, UK. · The Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK. · Institute for Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Ontario Institute for Cancer Research, MaRS Centre, Toronto, ON, Canada. · University of Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. · Department of Medical Oncology, NHS Lothian, Western General Hospital, Edinburgh, UK. · Pubmed 28548129
  • Department of Oncology, University of Cambridge, Cambridge. · NIHR Cambridge Biomedical Research Centre, Cambridge. · Cambridge Breast Cancer Research Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Warwick Clinical Trials Unit, University of Warwick, Coventry. · Cambridge Clinical Trials Unit - Cancer Theme, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Department of Oncology, Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, King's Lynn. · Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge. · Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Department of Oncology, Peterborough and Stamford Hospitals NHS Foundation Trust, Peterborough. · Department of Oncology, Nottingham City Hospital, Nottingham. · Department of Oncology, West Middlesex University Hospital, Isleworth. · Department of Oncology, Poole Hospital NHS Foundation Trust/Bournemouth University, Poole. · Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, UK. · Ontario Institute for Cancer Research, MaRS Centre, Toronto, Canada. · Cancer Research Centre, University of Edinburgh, IGMM, Western General Hospital, Edinburgh. · Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Department of Pathology, University of Edinburgh, Edinburgh, UK. · Pubmed 28459938
2016
  • Karolinska Institutet and University Hospital, Stockholm, Sweden · Sunnybrook Odette Cancer Centre and University of Toronto, Toronto, Ontario, Canada. · University of Edinburgh Cancer Research Centre, Edinburgh, United Kingdom. · Pubmed 26786914
  • MRC Clinical Trials Unit, UCL, Aviation House, 125 Kingsway, London WC2B 6NH, UK. · Independent Cancer Patient Voices, 17 Woodbridge Street, London EC1R 0LL, UK. · NCRI Consumer Forum, Angel Building, 407 St John Street, London EC1V 4AD, UK. · Room No. 1109, 11th Floor, Homi Bhabha Block, Tata Memorial Centre/Hospital, Parel, Mumbai 400012, India. · Department of Surgical Oncology, Tata Memorial Centre, Dr Ernest Borges Marg, Parel, Mumbai 400012, India. · MRC Clinical Trials Unit, UCL, Aviation House, 125 Kingsway, London WC2B 6NH, UK; Sussex Cancer Centre, Royal Sussex County Hospital, Eastern Road, Brighton, Sussex BN2 5BE, UK. · Room 2F65, Block A2, Cardiff School of Medicine, Heath Park, Cardiff CF14 4XN, UK. · Edinburgh Cancer Research Centre, University of Edinburgh, Western General Hospital, Crewe Road South, EH4 2XR, UK. · Centre for Cancer Research and Cell Biology, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, Northern Ireland, UK. · The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey SM2 5PT, UK. · MRC Clinical Trials Unit, UCL, Aviation House, 125 Kingsway, London WC2B 6NH, UK. Electronic address: · Pubmed 27777129
  • EORTC-Headquarters, Medical Department, Brussels, Belgium. Electronic address: · Acıbadem Üniversitesi İç Hastalıkları/Tıbbi Onkoloji, Turkey. Electronic address: · EORTC-Headquarters, Statistical Department, Belgium. Electronic address: · Institute Bergonie, Bordeaux, France. Electronic address: · GZA Sint Augustinus, Antwerp, Belgium. Electronic address: · Ctr Becquerel-Rouen, France. Electronic address: · Radboudumc Nijmegen/Maastricht UMC+, Netherlands. Electronic address: · ZNA Middelheim, Belgium. Electronic address: · University Clinic Golnik, Slovenia. Electronic address: · Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. Electronic address: · NHS-Lothian, University of Edinburgh, Edinburgh, United Kingdom. Electronic address: · Pubmed 26724641
  • Department of Oncology, University College London Hospitals, London, UK. · Warwick Medical School, University of Warwick, Coventry, UK. · Ontario Institute for Cancer Research, Toronto, ON, Canada. · Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK. · School of Social and Community Medicine, University of Bristol, Bristol, UK. · Independent Cancer Patients' Voice, London, UK. · Research Oncology, Division of Cancer Studies, King's College London, London, UK. · Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK. · Department of Emergency Medicine, University of Alberta, Edmonton, AB, Canada. · Oncology Centre, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundations Trust, Cambridge, UK. · Department of Clinical Oncology, Mount Vernon Cancer Centre, Mount Vernon Hospital, Northwood, UK. · Pubmed 26867046
  • Leeds Institute for Clinical Trials Research (LICTR), University of Leeds, Clinical Trials Research House, 71-75 Clarendon Road, Leeds, LS2 9JT, UK. · Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Deakin University, Geelong, Australia. · St. James's Academic Division of Medical Physics, University of Leeds, Leeds, UK. · Leeds Institute for Clinical Trials Research (LICTR), University of Leeds, Clinical Trials Research House, 71-75 Clarendon Road, Leeds, LS2 9JT, UK. · Sheffield Cancer Research Centre, Sheffield, UK. · Edinburgh University, Edinburgh, Scotland. · Pubmed 26783036
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue Yawkey, Boston, 1238, USA. · Department of Medical Oncology and Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Frontier Science (Scotland) Ltd, Kincraig, Kingussie, UK. · Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Breast Unit, Royal Marsden Hospital, and Institute of Cancer Research, London, UK. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Edinburgh Cancer Research Centre, Western general Hospital, University of Edinburgh, Crewe Road South, Edinburgh, UK. · Department of Gynecology and Obstetrics and Multidisciplinary Breast Cancer Center, Helios Klinikum, Berlin-Buch, Germany. · Department of Gynecology and Obstetrics, Klinikum Off enbach, Off Enbach, Germany. · Department of Medical Oncology, The Andrew Love Cancer Centre, Deakin University, Geelong, Australia. · Department of Medical Oncology, San Raffaele Institute, Milan, Italy. · European Institute of Oncology, Milan, Italy. · Swiss Center for Breast Health, Sant'Anna Clinic, Lugano-Sorengo, Switzerland. · Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute, Harvard School of Public Health, Harvard Medical School, Boston, USA. · Pubmed 26708471
2015
  • Department of Histopathology and NIH Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, UK. · Department of Pathology, Yale University, New Haven, CT, USA. · Department of Pathology, European Institute of Oncology and University of Milan, Milan, Italy. · Edinburgh Cancer Research UK Centre,University of Edinburgh, Edinburgh, UK. · Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA. · Institute of Pathology, Charité Hospital, Berlin, Germany. · Department of Biopathology, Institut Bergonié, Bordeaux, France. · Department of Pathology, Centre Jean Perrin and Université d'Auvergne, Clermont-Ferrand, France. · Division of Subspecialty General Surgery, Mayo Clinic, Rochester, MN, USA. · Early Drug Development for Innovative Therapies Division, European Institute of Oncology, Milan, Italy. · Edinburgh Breast Unit, Western General Hospital, Edinburgh, UK. · Carol Franc Buck Breast Care Center, University of California, San Francisco, CA, USA. · Department of Radiotherapy and Radiation Oncology, Landeskrankenhaus, Paracelsus Medical University, Salzburg, Austria. · Department of Gynecology and Obstetrics, Interdisciplinary Breast Center, Klinikum Esslingen, Esslingen, Germany. · Institute of Pathology, Medical University of Graz, Graz, Austria. · Department of Gynecology, General Hospital Leoben, Leoben, Austria. · German Breast Group, Neu-Isenburg, and Department of Gynecology and Obstetrics, University Women's Hospital, Frankfurt, Germany. · Department of Radiation Oncology, Ohio State University, Columbus, OH, USA. · Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26205180
  • University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK; NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK. Electronic address: · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Cambridge Clinical Trials Unit-Cancer Theme, Cambridge University Hospitals NHS Foundation Trust, UK. · University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK; NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Western General Hospital, Edinburgh, UK. · NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Cancer Research UK Cambridge Institute, Cambridge, UK. · Peterborough City Hospital, Edith Cavell Campus, Peterborough, UK. · Nottingham University Hospital (City Campus), Nottingham, UK. · West Middlesex University Hospital, Isleworth, UK. · Royal Bournemouth Hospital, Bournemouth University, Bournemouth, UK. · The Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK. · City Hospital, Dudley Road, Birmingham, UK. · Ontario Institute for Cancer Research, MaRS Centre, Toronto, Ontario, Canada; Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. · University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK; NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK; Cancer Research UK Cambridge Institute, Cambridge, UK. · Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. · Pubmed 25975632
  • Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK. Electronic address: · Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK. · Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK. · Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK. · Pubmed 25637340
  • University of Edinburgh Cancer Research Centre, Institute of Genetics and Molecular Medicine, Western General Hospital, Edinburgh EH4 2XU, UK. Electronic address: · Pubmed 26363986
  • School of Pharmacy, Queen's University Belfast, Belfast, United Kingdom. · Warwick Clinical Trials Unit, University of Warwick, Coventry, United Kingdom. · Conway Institute, University College Dublin, Dublin, Ireland. · Ontario Institute for Cancer Research, Toronto, Canada. · Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, United Kingdom. · Royal College of Surgeons Ireland, Dublin, Ireland. · Northern Ireland Molecular Pathology Laboratory, CCRCB, Queens University Belfast, Belfast, United Kingdom. · Department of Pathology, Royal Group of Hospitals, Grosvenor Road, Belfast, United Kingdom. · Edinburgh Breast Unit, The University of Edinburgh, Edinburgh, United Kingdom. · Department of Clinical Sciences, Lund University, Sweden. · Edinburgh Cancer Research Centre, The University of Edinburgh, Edinburgh, United Kingdom. · Pubmed 25906750
  • US Food and Drug Administration, Silver Spring, MD 20993, USA. Electronic address: · Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · San Raffaele Scientific Institute, Milan, Italy. · Edinburgh Cancer Research Center, University of Edinburgh and NHS Lothian, Edinburgh, UK. · German Breast Group, Neu-Isenburg, Germany. · Pubmed 25706464
2014
  • US Food and Drug Administration, Silver Spring, MD, USA. Electronic address: · US Food and Drug Administration, Silver Spring, MD, USA. · HELIOS Klinikum, Berlin, Germany. · German Breast Group, Neu-Isenburg, Germany. · National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA. · Institut Bergonié INSERM U916 and Université Bordeaux Segalen, Bordeaux, France. · Edinburgh Cancer Research Centre, University of Edinburgh and NHS Lothian, UK. · San Raffaele Scientific Institute, Milan, Italy. · Fondazione Michelangelo, Milan, Italy. · Medstar Washington Hospital Center, Washington, DC, USA. · EORTC Headquarters, Brussels, Belgium. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. · St Gertrauden Hospital, Berlin, Germany. · MD Anderson Cancer Center Orlando, Orlando, FL, USA. · KarolinskaInstitutet and University Hospital, Stockholm, Sweden. · NN Petrov Research Institute of Oncology, St Petersburg, Russia. · University Women's Hospital, Kiel, Germany. · Jules Bordet Institute, Brussels, Belgium. · Frauenklinik des Universitätsklinikums, Erlangen, Germany. · Universitäts Frauenklinik, Rostock, Germany. · Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · Hospital of the Ludwig Maximilian University of Munich, Munich, Germany. · Pubmed 24529560
  • CR-UK/YCR Sheffield Cancer Research Centre, Weston Park Hospital, University of Sheffield, Sheffield, UK. Electronic address: · Edinburgh Cancer Research Centre, Western General Hospital, University of Edinburgh, Edinburgh, UK. · St James Institute of Oncology, University of Leeds, Leeds, UK. · Andrew Love Cancer Centre, Geelong, VIC, Australia. · CR-UK/YCR Sheffield Cancer Research Centre, Weston Park Hospital, University of Sheffield, Sheffield, UK. · CR-UK/YCR Sheffield Cancer Research Centre, Weston Park Hospital, University of Sheffield, Sheffield, UK; St James Institute of Oncology, University of Leeds, Leeds, UK. · University Hospital Galway, Galway, Ireland. · Institut Català d'Oncologia - IDIBELL. L'Hospitalet de Llobregat, Barcelona, Spain. · University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK. · Velindre Cancer Center, Whitchurch, Cardiff, UK. · Beatson West of Scotland Cancer Centre, Glasgow, UK. · Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK. · Pubmed 25035292
  • Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux, France · European Organisation for Research and Treatment of Cancer (EORTC), Brussels. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux, France. · Centre George-François Leclerc, Dijon. · Ensemble Hospitalier de L'Institut Curie, Hopital René Huguenin, St-Cloud. · Centre Paul Strauss, Strasbourg. · Centre Val D'Aurelle-Paul Lamarque, Montpellier, France. · Medical University, Gdansk, Poland. · Centre Henri Becquerel, Rouen, France. · Geneva University Hospital, Geneva Swiss Group for Clinical Cancer Research (SAKK), Bern. · Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. · Institute of Oncology, Ljubljana University Clinic Golnik, Golnik, Slovenia. · Institut de Cancérologie de L'Ouest (ICO), Centre René Gauducheau, Nantes Centre Paul Papin, Angers. · Centre Alexis Vautrin, Nancy, France. · Department of Clinical Sciences, Lund University, Lund Skåne Department of Oncology, Skåne University Hospital, Lund. · Swedish Breast Cancer Group (SweBCG), Stockholm Department of Oncology, Karolinska Institutet, Radiumhemmet and Karolinska University Hospital, Stockholm, Sweden. · Cancer Services, Edinburgh University Anglo-Celtic Cooperative Oncology Group (ACCOG), Edinburgh, UK. · Pubmed 24618153
  • Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK. · Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK. · Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK. · Leiden University Medical Center, Leiden, The Netherlands. · Department of Gynecological Oncology, University Hospital, Freiburg, Germany. · Department of Surgery, Athens University Medical School, Athens, Greece. · Oncology Center, St Augustinus, Antwerp, Belgium. · Department of Medical Oncology, Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands. · 1] Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK [2] Transformative Pathology, Ontario Institute for Cancer Research, Toronto, Canada. · Pubmed 25314051
  • MRC Centre for Reproductive Health, Queens Medical Research Institute, University of Edinburgh, Edinburgh, UK. · Edinburgh Breast Unit and Edinburgh University Cancer Research Centre, Western General Hospital, Edinburgh, UK. · MRC Centre for Reproductive Health, Queens Medical Research Institute, University of Edinburgh, Edinburgh, UK. Electronic address: · Pubmed 25027307
  • Edinburgh Cancer Centre, Western General Hospital, Edinburgh EH4 2XU, UK. Electronic address: · Pubmed 24333008
2013
  • University of Edinburgh and Cancer Services, NHS Lothian, Edinburgh, UK. · Pubmed 23932548
2010
2016
  • From the University of Texas M.D. Anderson Cancer Center, Houston (G.N.H.), and Texas Oncology-Baylor Charles A. Sammons Cancer Center and the U.S. Oncology Network, Dallas (J.O.) - all in Texas; Davidoff Center, Rabin Medical Center, Tel Aviv University, Tel Aviv (S.M.S.), and Sheba Medical Center, Ramat Gan (S.P.-S.) - both in Israel; the Sarah Cannon Research Institute (H.A.B., D.Y.), Vanderbilt-Ingram Cancer Center (C.L.A.), and Tennessee Oncology (D.Y.) - all in Nashville; National Cancer Center Singapore, Singapore (Y.-S.Y.); Netherlands Cancer Institute and BOOG Study Center, Amsterdam (G.S.S.); Institut de Cancérologie de l'Ouest/René Gauducheau, Saint-Herblain (M.C.), Institut Gustave Roussy, Université Paris Sud, Villejuif (F.A.), University Hospital of Besançon, Besançon (C.V.), and Centre Léon Bérard, Lyon (T.B.) - all in France; Duke University Medical Center, Durham, NC (K.L.B.); Dana-Farber Cancer Institute, Boston (E.P.W.); University of Ulm, Ulm (W.J.), Onkologische Praxis, Velbert (A.N.), University of Tübingen, Tübingen (E.-M.G.), and Joint Practice for Interdisciplinary Oncology and Hematology, Freiburg (N.M.) - all in Germany; Tom Baker Cancer Centre, Calgary, AB, Canada (S.V.); University of Padua and Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy (P.C.); Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh (D.A.C.); Masaryk Memorial Cancer Institute, Brno, Czech Republic (K.P.); Florida Cancer Specialists-Sarah Cannon Research Institute, Fort Myers (L.L.H.); Breast Cancer Research Centre-Western Australia and Curtin University, Perth, Australia (A.C.); Department of Oncology, Vejle Hospital, Vejle, Denmark (E.J.); Arkhangelsk Clinical Oncology Dispensary, Arkhangelsk, Russia (O.B.); Hospital Universitario Virgen de la Victoria, Institute of Biomedical Research in Málaga, Málaga, Spain (E.A.); Oslo University Hospital, Oslo (E.W.); Virginia Cancer Specialists, Arlington (A.M.F.); Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan (L.-M.T.); Rainier Hematology-Oncology, Northwest Medical Specialties, Puyallup, WA (S.B.); Novartis Pharmaceuticals, East Hanover, NJ (F.X., M.M., C.G., S.H.); and Novartis Pharma, Basel, Switzerland (F.S.). · Pubmed 27717303
  • Ontario Institute for Cancer Research, Toronto, Ontario, Canada (JMSB, JB); University of Toronto, Toronto, Canada (JMSB); University of Edinburgh, Edinburgh, UK (JMSB, CC, MSS, PSH, DAC); Warwick Clinical Trials Unit, University of Warwick, Coventry, UK (AM, JAD, AC); University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK (CJP); University of Cambridge Department of Oncology and NIHR Cambridge Biomedical Research Centre, Cambridge, UK (HME); Cancer Research UK Institute for Cancer Studies, University of Birmingham, Birmingham, UK (DWR); University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK (IRM, PC); University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK (AF); University of Alberta, Edmonton, AB, Canada (CM); Kings College London, Guy's Hospital, London, UK (SEP); Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK (LHD); Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, Middlesex, UK (AM); National Institute for Health Research University College London Hospitals Biomedical Research Centre, London, UK (RCS). · Ontario Institute for Cancer Research, Toronto, Ontario, Canada (JMSB, JB); University of Toronto, Toronto, Canada (JMSB); University of Edinburgh, Edinburgh, UK (JMSB, CC, MSS, PSH, DAC); Warwick Clinical Trials Unit, University of Warwick, Coventry, UK (AM, JAD, AC); University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK (CJP); University of Cambridge Department of Oncology and NIHR Cambridge Biomedical Research Centre, Cambridge, UK (HME); Cancer Research UK Institute for Cancer Studies, University of Birmingham, Birmingham, UK (DWR); University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK (IRM, PC); University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK (AF); University of Alberta, Edmonton, AB, Canada (CM); Kings College London, Guy's Hospital, London, UK (SEP); Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK (LHD); Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, Middlesex, UK (AM); National Institute for Health Research University College London Hospitals Biomedical Research Centre, London, UK (RCS). · Pubmed 27130929
  • Chee Khoon Lee, Lucy Davies, Val J. Gebski, Sarah J. Lord, Ian Marschner, and John Simes, University of Sydney; Sarah J. Lord, University of Notre Dame; Ian Marschner, Macquarie University; Paul de Souza, University of Western Sydney, Sydney, New South Wales; Sherene Loi, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Angelo Di Leo, Hospital of Prato, Istituto Toscano Tumori, Italy; Stephen Johnston, Royal Marsden Hospital, London; David Cameron, University of Edinburgh, Edinburgh, United Kingdom; Charles Geyer Jr, Virginia Commonwealth University Massey Cancer Center, Richmond, VA; Michael F. Press, University of Southern California, Los Angeles, CA; and Catherine Ellis, GlaxoSmithKline, Collegeville, PA. · Chee Khoon Lee, Lucy Davies, Val J. Gebski, Sarah J. Lord, Ian Marschner, and John Simes, University of Sydney; Sarah J. Lord, University of Notre Dame; Ian Marschner, Macquarie University; Paul de Souza, University of Western Sydney, Sydney, New South Wales; Sherene Loi, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Angelo Di Leo, Hospital of Prato, Istituto Toscano Tumori, Italy; Stephen Johnston, Royal Marsden Hospital, London; David Cameron, University of Edinburgh, Edinburgh, United Kingdom; Charles Geyer Jr, Virginia Commonwealth University Massey Cancer Center, Richmond, VA; Michael F. Press, University of Southern California, Los Angeles, CA; and Catherine Ellis, GlaxoSmithKline, Collegeville, PA. · Pubmed 26811533
2014
  • Evandro de Azambuja and Martine J. Piccart-Genhart, Institut Jules Bordet; Evandro de Azambuja, Breast European Adjuvant Study Team; Martine J. Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium; Marion J. Procter and Dominique Agbor-Tarh, Frontier Science Scotland, Kincraig, Kingussie; David A. Cameron, University of Edinburgh and Western General Hospital, Edinburgh; Ian E. Smith, Royal Marsden Hospital and the Institute of Cancer Research; Mitch Dowsett, the Royal Marsden National Health Service Trust, London, United Kingdom; Dirk J. van Veldhuisen, University of Groningen, Groningen, the Netherlands; Otto Metzger-Filho and Richard D. Gelber, Dana-Farber Cancer Institute, Boston, MA; Jutta Steinseifer, F. Hoffmann-La Roche, Basel; Thomas M. Suter, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, Bern, Switzerland; Michael Untch, HELIOS Klinikum Berlin, Buch; Christian Jackisch, Klinikum Offenbach, Offenbach, Germany; Luca Gianni, San Raffaele Institute, Milan, Italy; Jose Baselga, Memorial Sloan Kettering Cancer Center, New York, NY; Richard Bell, Andrew Love Cancer Centre, Geelong Hospital, Geelong, Australia; and Brian Leyland-Jones, Edith Sanford Breast Cancer Research Institute, Sioux Falls, SD. · Evandro de Azambuja and Martine J. Piccart-Genhart, Institut Jules Bordet; Evandro de Azambuja, Breast European Adjuvant Study Team; Martine J. Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium; Marion J. Procter and Dominique Agbor-Tarh, Frontier Science Scotland, Kincraig, Kingussie; David A. Cameron, University of Edinburgh and Western General Hospital, Edinburgh; Ian E. Smith, Royal Marsden Hospital and the Institute of Cancer Research; Mitch Dowsett, the Royal Marsden National Health Service Trust, London, United Kingdom; Dirk J. van Veldhuisen, University of Groningen, Groningen, the Netherlands; Otto Metzger-Filho and Richard D. Gelber, Dana-Farber Cancer Institute, Boston, MA; Jutta Steinseifer, F. Hoffmann-La Roche, Basel; Thomas M. Suter, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, Bern, Switzerland; Michael Untch, HELIOS Klinikum Berlin, Buch; Christian Jackisch, Klinikum Offenbach, Offenbach, Germany; Luca Gianni, San Raffaele Institute, Milan, Italy; Jose Baselga, Memorial Sloan Kettering Cancer Center, New York, NY; Richard Bell, Andrew Love Cancer Centre, Geelong Hospital, Geelong, Australia; and Brian Leyland-Jones, Edith Sanford Breast Cancer Research Institute, Sioux Falls, SD. · Pubmed 24912899
  • Department of Surgery and GROW School for Oncology and Developmental Biology (MM, MLS), Department of Surgery and Radiology (LMvR), Department of Medical Oncology, GROW School for Oncology and Developmental Biology (VCGTH), and Department of Epidemiology and GROW School for Oncology and Developmental Biology (ACV), Maastricht University Medical Center, Maastricht, the Netherlands; Department of Surgery, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands (LJAS); Division of Medical Oncology, Luzerner Kantonsspital, Lucerne, Switzerland (SA); Edinburgh Cancer Research Centre, University of Edinburgh and NHS Lothian (DAC), Edinburgh Breast Unit (JMD), Western General Hospital, Edinburgh, UK; Cedars-Sinai Medical Center, Los Angeles, CA (AEG); Rutgers Cancer Institute of New Jersey, New Brunswick, NJ (BGH); Mater Centre Radiation Oncology Service, Princess Alexandra Hospital, Brisbane, Australia (BEH); Breast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center and Professor of Medicine, Weill Cornell Medical College, New York, NY (CAH); University of Arkansas for Medical Sciences, Winthrop P. Rockefeller Cancer Institute, Little Rock, AR (VSK); Flinders Centre for Innovation in Cancer, Flinders University, Adelaide, Australia (BK); Interdisciplinary Breast Centre, Department of Gynaecology and Obstetrics, Klinikum Esslingen, Germany (TK); University of Miami Miller School of Medicine, Miami, FL (MEL); Radiation Oncology (BDS) and Department of Surgical Oncology, Division of Surgery (AL), University of Texas/MD Anderson Cancer Center, Houston, TX; Institut Jules Bordet, Université Libre de Bruxelles, Head of Medicine Department, Brussels, Belgium (MP); Surgery, University Medical Center, Leiden, the Netherlands (CJHvdV); Breast Service, Memorial Sloan-Kettering Cancer Center, Evelyn Lauder Breast Center, New York, NY(KJVZ); Antwerp University Hospital, Department of Medical Oncology, Edegem, Belgium (JBV); Department of Pathology, European Institute of · Pubmed 25381395
2013
  • Division of Pathology, Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road South, Edinburgh, EH4 2XU, UK. · Pubmed 23984893
  • From the Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Edinburgh Cancer Research UK Centre, University of Edinburgh, Edinburgh, United Kingdom; and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Pubmed 23714441
  • MRC Centre for Reproductive Health, University of Edinburgh, Queens Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, UK. Electronic address: · Pubmed 23968732
2012
  • Endocrine Cancer Group, Edinburgh Cancer Research UK Centre, MRC IGMM, University of Edinburgh, Crewe Road South, Edinburgh EH4 2XR, UK. · Pubmed 22644297
  • Edinburgh Cancer Centre, Western General Hospital, Edinburgh, United Kingdom. · Pubmed 22197227
  • Edinburgh Breakthrough Breast Cancer Unit, Edinburgh Cancer Research Centre, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK. · Pubmed 21638049
  • Breakthrough Breast Cancer, Edinburgh Cancer Research Centre, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK. · Pubmed 21390497
2011
  • Division of Reproduction and Developmental Sciences and Medical Research Council Human Reproductive Sciences Unit, Centre for Reproductive Biology, University of Edinburgh, Edinburgh EH16 4TJ, United Kingdom. · Pubmed 21325458
2010
  • Endocrine Cancer Group, Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. · Pubmed 20676126
  • Endocrine Cancer Group, Edinburgh Cancer Research Centre, Edinburgh University, Carrington Crescent, Edinburgh EH4 2XU, UK. · Pubmed 20615243
  • CRUK Cancer Research Centre and Academic Breast Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road South, Edinburgh, UK. · Pubmed 20569502
  • Endocrine Cancer Group, Edinburgh University, Edinburgh, UK. · Pubmed 20079691
2009
  • Edinburgh Breast Unit, Western General Hospital, Edinburgh, UK. · Pubmed 19845790
University of London
2017
  • Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, UK. Electronic address: · Clinical Trials Research Unit, University of Leeds, Leeds, UK. · IMIM-CIBERONC, Barcelona; Medical Oncology Department, Hospital del Mar, Barcelona, Spain; Pompeu Fabra University, Barcelona, Spain. · Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Deakin University, Geelong, VIC, Australia. · Cancer Research UK Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK. · St James Institute of Oncology, St James Hospital, Leeds, UK. · Inbiomotion, Barcelona, Spain. · Fundación Jiménez Díaz, Madrid, Spain; CIBERONC, Madrid, Spain. · IMIM-CIBERONC, Barcelona; Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. · Pubmed 29037984
  • Cancer Research UK Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK. Electronic address: · ICR-CTSU, Division of Clinical Studies, Institute of Cancer Research, London, UK. · Department of Oncology, Beatson Hospital, Glasgow, UK. · St James' Institute of Oncology, University of Leeds, Leeds, UK. · Department of Oncology, Weston Park Hospital, Sheffield, UK. · Department of Diagnostic Development, Ontario Institute for Cancer Research, Toronto, ON, Canada. · Department of Oncology, Shrewsbury & Telford Hospitals NHS Trust, Shrewsbury, UK. · Department of Oncology, Singleton Hospital, Swansea, UK. · Department of Oncology, Royal Sussex County Hospital, Brighton, UK. · Department of Oncology, Royal Stoke University Hospital, Stoke-on-Trent, UK. · Department of Oncology, Addenbrooke's Hospital, Cambridge, UK. · Department of Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK. · Cancer Research UK Clinical Trials Unit, University of Birmingham, UK. · Clinical Trials Research Unit (CTRU), University of Leeds, Leeds, UK. · Department of Oncology, Royal Surrey County Hospital, Guildford, UK. · Department of Oncology, Southampton General Hospital, Southampton, UK. · Cancer Clinical Trials Unit Scotland (CaCTUS), Glasgow, UK. · Department of Oncology, NIHR University College London Hospitals Biomedical Research Centre, London, UK. · Department of Oncology, Northern Centre for Cancer Care, Freeman Hospital, Newcastle, UK. · Department of Oncology, Christie Hospital, Manchester, UK. · Department of Oncology, Velindre NHS Trust, Cardiff, UK. · Pubmed 28600210
  • Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge, UK. Electronic address: · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Leeds Institute for Clinical Trials Research, University of Leeds, Leeds, UK. · Cancer Research UK Clinical Trials Unit (CRCTU), Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. · Scottish Clinical Trials Research Unit, NHS Natio nal Services Scotland, Edinburgh, UK. · The Christie NHS Foundation Trust, Manchester, UK. · Department of Oncology, Shrewsbury & Telford Hospitals NHS Trust, Shrewsbury, UK. · Department of Oncology, Clatterbridge Cancer Centre, Wirral, UK. · Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK. · Department of Oncology, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Exeter Oncology Centre, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK. · Department of Oncology, Poole Hospital, Poole Hospital NHS Foundation Trust/Bournemouth University, Poole, Dorset, UK. · Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Edith Cavell Campus, Peterborough City Hospital, Peterborough and Stamford Hospitals NHS Foundation Trust, Peterborough, UK. · Cancer Research UK Edinburgh Centre, MRC Institute of Genetics & Molecular Medicine, University of Edinburgh, Edinburgh, UK. · Institute of Oncology, St James's University Hospital, Leeds Teaching Hospital NHS Trust, Leeds, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge UK; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge, UK. · NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Department of Histopathology, Cambridge, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge, UK. · Cancer Clinical Trials Unit (CaCTUS), Beatson West of Scotland Cancer Centre, Glasgow, UK. · Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland. · Cancer Trials Ireland (formerly ICORG), Dublin, Ireland. · Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, UK. · Department of Surgery and Cancer, Charing Cross Hospital, Imperial College London, London, UK. · Celgene, Research and Development, San Diego, CA, USA. · NIHR/CRUK Christie Clinical Research Facility, Manchester, UK. · Arden Cancer Research Centre, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK. · Pubmed 28479233
2015
  • University of Edinburgh Cancer Research Centre, Institute of Genetics and Molecular Medicine, Western General Hospital, Edinburgh EH4 2XU, UK. Electronic address: · Pubmed 26363986
2016
  • From the University of Texas M.D. Anderson Cancer Center, Houston (G.N.H.), and Texas Oncology-Baylor Charles A. Sammons Cancer Center and the U.S. Oncology Network, Dallas (J.O.) - all in Texas; Davidoff Center, Rabin Medical Center, Tel Aviv University, Tel Aviv (S.M.S.), and Sheba Medical Center, Ramat Gan (S.P.-S.) - both in Israel; the Sarah Cannon Research Institute (H.A.B., D.Y.), Vanderbilt-Ingram Cancer Center (C.L.A.), and Tennessee Oncology (D.Y.) - all in Nashville; National Cancer Center Singapore, Singapore (Y.-S.Y.); Netherlands Cancer Institute and BOOG Study Center, Amsterdam (G.S.S.); Institut de Cancérologie de l'Ouest/René Gauducheau, Saint-Herblain (M.C.), Institut Gustave Roussy, Université Paris Sud, Villejuif (F.A.), University Hospital of Besançon, Besançon (C.V.), and Centre Léon Bérard, Lyon (T.B.) - all in France; Duke University Medical Center, Durham, NC (K.L.B.); Dana-Farber Cancer Institute, Boston (E.P.W.); University of Ulm, Ulm (W.J.), Onkologische Praxis, Velbert (A.N.), University of Tübingen, Tübingen (E.-M.G.), and Joint Practice for Interdisciplinary Oncology and Hematology, Freiburg (N.M.) - all in Germany; Tom Baker Cancer Centre, Calgary, AB, Canada (S.V.); University of Padua and Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy (P.C.); Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh (D.A.C.); Masaryk Memorial Cancer Institute, Brno, Czech Republic (K.P.); Florida Cancer Specialists-Sarah Cannon Research Institute, Fort Myers (L.L.H.); Breast Cancer Research Centre-Western Australia and Curtin University, Perth, Australia (A.C.); Department of Oncology, Vejle Hospital, Vejle, Denmark (E.J.); Arkhangelsk Clinical Oncology Dispensary, Arkhangelsk, Russia (O.B.); Hospital Universitario Virgen de la Victoria, Institute of Biomedical Research in Málaga, Málaga, Spain (E.A.); Oslo University Hospital, Oslo (E.W.); Virginia Cancer Specialists, Arlington (A.M.F.); Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan (L.-M.T.); Rainier Hematology-Oncology, Northwest Medical Specialties, Puyallup, WA (S.B.); Novartis Pharmaceuticals, East Hanover, NJ (F.X., M.M., C.G., S.H.); and Novartis Pharma, Basel, Switzerland (F.S.). · Pubmed 27717303
  • Ontario Institute for Cancer Research, Toronto, Ontario, Canada (JMSB, JB); University of Toronto, Toronto, Canada (JMSB); University of Edinburgh, Edinburgh, UK (JMSB, CC, MSS, PSH, DAC); Warwick Clinical Trials Unit, University of Warwick, Coventry, UK (AM, JAD, AC); University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK (CJP); University of Cambridge Department of Oncology and NIHR Cambridge Biomedical Research Centre, Cambridge, UK (HME); Cancer Research UK Institute for Cancer Studies, University of Birmingham, Birmingham, UK (DWR); University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK (IRM, PC); University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK (AF); University of Alberta, Edmonton, AB, Canada (CM); Kings College London, Guy's Hospital, London, UK (SEP); Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK (LHD); Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, Middlesex, UK (AM); National Institute for Health Research University College London Hospitals Biomedical Research Centre, London, UK (RCS). · Ontario Institute for Cancer Research, Toronto, Ontario, Canada (JMSB, JB); University of Toronto, Toronto, Canada (JMSB); University of Edinburgh, Edinburgh, UK (JMSB, CC, MSS, PSH, DAC); Warwick Clinical Trials Unit, University of Warwick, Coventry, UK (AM, JAD, AC); University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK (CJP); University of Cambridge Department of Oncology and NIHR Cambridge Biomedical Research Centre, Cambridge, UK (HME); Cancer Research UK Institute for Cancer Studies, University of Birmingham, Birmingham, UK (DWR); University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK (IRM, PC); University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK (AF); University of Alberta, Edmonton, AB, Canada (CM); Kings College London, Guy's Hospital, London, UK (SEP); Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK (LHD); Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, Middlesex, UK (AM); National Institute for Health Research University College London Hospitals Biomedical Research Centre, London, UK (RCS). · Pubmed 27130929
2014
  • Evandro de Azambuja and Martine J. Piccart-Genhart, Institut Jules Bordet; Evandro de Azambuja, Breast European Adjuvant Study Team; Martine J. Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium; Marion J. Procter and Dominique Agbor-Tarh, Frontier Science Scotland, Kincraig, Kingussie; David A. Cameron, University of Edinburgh and Western General Hospital, Edinburgh; Ian E. Smith, Royal Marsden Hospital and the Institute of Cancer Research; Mitch Dowsett, the Royal Marsden National Health Service Trust, London, United Kingdom; Dirk J. van Veldhuisen, University of Groningen, Groningen, the Netherlands; Otto Metzger-Filho and Richard D. Gelber, Dana-Farber Cancer Institute, Boston, MA; Jutta Steinseifer, F. Hoffmann-La Roche, Basel; Thomas M. Suter, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, Bern, Switzerland; Michael Untch, HELIOS Klinikum Berlin, Buch; Christian Jackisch, Klinikum Offenbach, Offenbach, Germany; Luca Gianni, San Raffaele Institute, Milan, Italy; Jose Baselga, Memorial Sloan Kettering Cancer Center, New York, NY; Richard Bell, Andrew Love Cancer Centre, Geelong Hospital, Geelong, Australia; and Brian Leyland-Jones, Edith Sanford Breast Cancer Research Institute, Sioux Falls, SD. · Evandro de Azambuja and Martine J. Piccart-Genhart, Institut Jules Bordet; Evandro de Azambuja, Breast European Adjuvant Study Team; Martine J. Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium; Marion J. Procter and Dominique Agbor-Tarh, Frontier Science Scotland, Kincraig, Kingussie; David A. Cameron, University of Edinburgh and Western General Hospital, Edinburgh; Ian E. Smith, Royal Marsden Hospital and the Institute of Cancer Research; Mitch Dowsett, the Royal Marsden National Health Service Trust, London, United Kingdom; Dirk J. van Veldhuisen, University of Groningen, Groningen, the Netherlands; Otto Metzger-Filho and Richard D. Gelber, Dana-Farber Cancer Institute, Boston, MA; Jutta Steinseifer, F. Hoffmann-La Roche, Basel; Thomas M. Suter, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, Bern, Switzerland; Michael Untch, HELIOS Klinikum Berlin, Buch; Christian Jackisch, Klinikum Offenbach, Offenbach, Germany; Luca Gianni, San Raffaele Institute, Milan, Italy; Jose Baselga, Memorial Sloan Kettering Cancer Center, New York, NY; Richard Bell, Andrew Love Cancer Centre, Geelong Hospital, Geelong, Australia; and Brian Leyland-Jones, Edith Sanford Breast Cancer Research Institute, Sioux Falls, SD. · Pubmed 24912899
  • Department of Surgery and GROW School for Oncology and Developmental Biology (MM, MLS), Department of Surgery and Radiology (LMvR), Department of Medical Oncology, GROW School for Oncology and Developmental Biology (VCGTH), and Department of Epidemiology and GROW School for Oncology and Developmental Biology (ACV), Maastricht University Medical Center, Maastricht, the Netherlands; Department of Surgery, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands (LJAS); Division of Medical Oncology, Luzerner Kantonsspital, Lucerne, Switzerland (SA); Edinburgh Cancer Research Centre, University of Edinburgh and NHS Lothian (DAC), Edinburgh Breast Unit (JMD), Western General Hospital, Edinburgh, UK; Cedars-Sinai Medical Center, Los Angeles, CA (AEG); Rutgers Cancer Institute of New Jersey, New Brunswick, NJ (BGH); Mater Centre Radiation Oncology Service, Princess Alexandra Hospital, Brisbane, Australia (BEH); Breast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center and Professor of Medicine, Weill Cornell Medical College, New York, NY (CAH); University of Arkansas for Medical Sciences, Winthrop P. Rockefeller Cancer Institute, Little Rock, AR (VSK); Flinders Centre for Innovation in Cancer, Flinders University, Adelaide, Australia (BK); Interdisciplinary Breast Centre, Department of Gynaecology and Obstetrics, Klinikum Esslingen, Germany (TK); University of Miami Miller School of Medicine, Miami, FL (MEL); Radiation Oncology (BDS) and Department of Surgical Oncology, Division of Surgery (AL), University of Texas/MD Anderson Cancer Center, Houston, TX; Institut Jules Bordet, Université Libre de Bruxelles, Head of Medicine Department, Brussels, Belgium (MP); Surgery, University Medical Center, Leiden, the Netherlands (CJHvdV); Breast Service, Memorial Sloan-Kettering Cancer Center, Evelyn Lauder Breast Center, New York, NY(KJVZ); Antwerp University Hospital, Department of Medical Oncology, Edegem, Belgium (JBV); Department of Pathology, European Institute of · Pubmed 25381395
2013
  • From the Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Edinburgh Cancer Research UK Centre, University of Edinburgh, Edinburgh, United Kingdom; and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Pubmed 23714441
2010
  • Department of Medical Oncology, Guy's and St Thomas' Hospital, Guy's and St Thomas' Foundation Trust and King's College London Biomedical Research Centre, 4th Floor, Bermondsey Wing, Great Maze Pond, London SE1 9RT, UK. · Pubmed 20559708
  • CRUK Cancer Research Centre and Academic Breast Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road South, Edinburgh, UK. · Pubmed 20569502
Miscellaneous institutions in Edinburgh
2017
  • Indiana University School of Medicine, Indianapolis, Indiana. · Indiana University School of Medicine, Indianapolis, Indiana. · Dana Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, Massachusetts. · Albert Einstein University, Montefiore Medical Center, Bronx, New York. · University of Pittsburgh Cancer Center, Pittsburgh, Pennsylvania. · Edinburgh Cancer Research Centre, Edinburgh, United Kingdom. · Swiss Cardiovascular Center, Bern University Hospital, Inselspital, Bern, Switzerland. · Stanford University School of Medicine, Stanford, California. · Pubmed 27993963
University of Leeds
2010
2008
  • NCRN Co-ordinating Centre, University of Leeds, Leeds, UK. · Pubmed 19128446
2012
  • Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, UK. · Pubmed 22138097
2011
  • Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK. · Pubmed 21504241
Miscellaneous institutions in Leeds
2009
  • NCRN Co-ordinating Centre, MacMillan House, Fairburn House, 71-75 Clarendon Road, Leeds LS2 9LN, UK. · Pubmed 20030875
84 Other Locations Show
Yearly article counts 114969179914910
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.